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Abstract 
 
Many virus infections induce a transient state of immune suppression in the 
infected host.  Virus-induced T cell suppression can be caused by T cell activation-
induced cell death (AICD), dendritic cell (DC) apoptosis, DC dysfunction, and/or the 
enhanced expression of immune-suppressive cytokines.  It has been previously 
demonstrated that naïve bystander CD8 T cells derived from hosts experiencing an acute 
virus-specific T cell response underwent AICD when polyclonally activated by anti-CD3 
in vitro (Zarozinski et al., 2000).  Susceptibility of naïve bystander T cells to AICD could 
prevent the development of a new T cell response during an ongoing immune response, 
and thus render infected hosts immune suppressed.  Although immune suppression could 
result in an enhanced susceptibility to superinfections, virus-infected individuals are more 
commonly resistant to superinfecting pathogens.  Because of these seemingly 
contradictory conditions, we sought to investigate how acute viral infections impact naïve 
bystander CD8 T cells in vivo.  More specifically, we asked whether bystander CD8 T 
cells are susceptible to immune suppression or whether they can contribute to the 
resistance to superinfections.  In order to address this, we examined the responses of 
bystander CD8 T cells activated with cognate antigen during acute viral infections in 
vivo.   We generated several in vivo models using P14 (LCMV glycoprotein-specific), 
HY (male antigen-specific), and OT-I (ovalbumin-specific) transgenic CD8 T cells, 
which we defined as bystander during acute infections with lymphocytic 
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choriomeningitis virus (LCMV), Pichinde virus (PV), vaccinia virus (VV), and murine 
cytomegalovirus (MCMV).  
Consistent with the enhanced susceptibility to cell death noted in vitro, we found 
that bystander CD8 T cells activated with cognate antigen in vivo during acute viral 
infections underwent markedly reduced proliferation.  Virus-induced transient T cell 
suppression in vivo was not exclusively mediated by Fas-FasL- or TNF-induced AICD or 
due to an enhanced susceptibility to apoptosis.  Instead, immune suppression in vivo was 
associated with a delayed onset of division, which we found not to be due to a defect in 
antigen presentation, but rather due to a T cell intrinsic defect.  
Despite the suppressed proliferation of TCR-stimulated bystander CD8 T cells in 
vivo, we found an enhancement of the effector functions exerted by bystander CD8 T 
cells activated during acute viral infections.  During acute viral infections or after 
stimulation with type 1 IFN (IFN-αβ) inducers, some bystander CD8 T cells were 
sensitized to immediately exert effector functions such as IFN-γ production and 
degranulation upon stimulation with high affinity cognate antigen.  Sensitization of naïve 
CD8 T cells required self-MHC I and indirect effects of IFN-αβ, while IL-12, IL-18, and 
IFN-γ were not individually required.  IL-15 was not required for the rapid expression of 
IFN-γ, but was required for up-regulation of granzyme B (GrzB).  P14 and OT-I CD8 T 
cells, which are capable of homeostatic proliferation, could be sensitized by poly(I:C), 
but HY CD8 T cells, which are poor at homeostatic proliferation, could not, suggesting 
that the requirement for MHC I may be to present low affinity cryptically cross-reactive 
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self antigens.  Sensitized naive CD8 T cells up-regulated the t-box transcription factor 
Eomesodermin (Eomes), which can regulate these rapid effector functions.   
In conclusion, we demonstrate in this thesis that acute viral infections impact 
naïve bystander CD8 T cells such that their response to cognate antigen is altered.  Prior 
to cognate antigen engagement, bystander CD8 T cells up-regulated Eomes, CD122, and 
GrzB.  Following cognate antigen engagement, bystander CD8 T cells rapidly 
degranulated and expressed the effector cytokine IFN-γ.  The ability of bystander CD8 T 
cells to rapidly exert effector functions may contribute to the resistance of virus-infected 
individuals to superinfections.  Despite these rapid effector functions, the proliferation of 
TCR-stimulated bystander CD8 T cells was markedly inhibited.  This reduced 
proliferation was found not to be a defect in antigen presentation, but was a T cell 
intrinsic defect in initiating division.  Thus, bystander CD8 T cells were also susceptible 
to virus-induced immune suppression.   
It is also likely that virus-specific CD8 T cells that are not activated until later in 
the response, so-called latecomer CD8 T cells, may also be susceptible to immune 
enhancement and suppression.  Thus, latecomer CD8 T cells would be able to rapidly 
exert effector functions at the expense of proliferation.  Taken together, we propose that 
during an immune response, due to spatial and temporal gradients of antigen and 
inflammation, it is likely that a combination of heterogeneous T cells with different signal 
strengths and sequences of exposure from cytokines and peptide-MHC constitute the total 
T cell response to pathogens.   
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Chapter I:  Introduction 
  
A.  Generation of TCR diversity and recognition of peptide-MHC 
 The diversity of the T cell repertoire in an individual is generated by somatic 
rearrangement of germline V, D, and J gene segments, deletion or insertion events at the 
junctions of these segments, and combinatorial diversity of protein chains (Davis and 
Bjorkman, 1988). The germline-encoded TCR segments have broad reactivity with self-
MHC molecules (Germain, 1990; Jerne, 1971), while the junctions, or complement-
determining regions (CDR) react with peptides bound by the MHC molecule.  T cells 
develop in the thymus and are positively selected based on their ability to bind self-
peptide-MHC with an intermediate affinity.  Those T cells that recognize self-peptide 
with high affinity undergo negative selection and those T cells that do not recognize self-
peptide-MHC undergo death by neglect.  The process of T cell selection in the thymus 
imparts central tolerance, such that mature naïve T cells that exit the thymus will have 
some reactivity to MHC, but little reactivity to self-peptides that would result in 
autoimmunity.  Reactivity to self-MHC is not only necessary for a proper T cell response 
to foreign antigen-loaded MHC, but also for peripheral T cell survival in vivo (Brocker, 
1997; Kassiotis et al., 2002; Kirberg et al., 1997; Markiewicz et al., 1998; Polic et al., 
2001; Tanchot et al., 1997). 
 MHC molecules are polymorphic membrane-bound proteins with peptide binding 
segments that are the target of interaction with the TCR.  Alleles of MHC proteins differ 
in their peptide-binding pockets, resulting in the ability of each allele to bind to only 
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certain peptide sequences or motifs (Garrett et al., 1989; Matsumura et al., 1992; Stern 
and Wiley, 1994).   Most peptides that can stably bind MHC will have the proper motif 
for that MHC, but other peptides may interact with faster off-rates (Cerundolo et al., 
1991).  In general, MHC molecules cannot discriminate between self- or pathogen-
encoded peptides.  The result is that even on infected cells, the majority of MHC 
molecules will be presenting peptides derived from the abundant self-protein pool (Chicz 
et al., 1992; Hunt et al., 1992; Rudensky et al., 1991).  Due to the diverse nature of TCRs 
and the diverse pool of peptide ligands, any given TCR will bind an array of peptide-
MHC molecules with a variety of affinities that results in a continuum of agonist, partial 
agonist, antagonist, and non-reactive TCR-peptide pairs (Evavold et al., 1995; Williams 
et al., 1998).  Consistent with this idea, it has been estimated that a single TCR may be 
able to recognize up to one million peptide-MHC complexes (Mason, 1998).  The 
signaling events resulting from these associations will determine the response, or lack-
there-of, of a given T cell.  
 
B.  T cell activation 
 Signaling from the TCR is a complex cascade of phosphorylation events that 
culminate in cytoskeleton rearrangement and gene expression (Figure 1.1).  The cascade 
begins with the activation of src family kinases, most notably Lck (Samelson et al., 1986; 
Straus and Weiss, 1992).  Active Lck phosphorylates the tyrosines in the TCR ζ chain 
and CD3 ε, γ, and δ chains in their immunoreceptor tyrosine-based activation motifs 
(ITAM) (Wange and Samelson, 1996).  ZAP-70 is recruited and binds to the 
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Figure 1.1.  T cell receptor signaling cascades.  (Acuto et al., 2008) 
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phosphorylated ITAM in the TCR ζ chain, where it is subsequently phosphorylated by 
Lck (Chan et al., 1995; Isakov et al., 1995).  Kinase-active ZAP-70 then phosphorylates 
an adapter protein called LAT (Zhang et al., 1998a), which associates with SLP-76 via 
the adapter molecule Gads (Liu et al., 1999).  Itk is recruited to this complex and 
mediates the phosphorylation and activation of PLC-γ (Bunnell et al., 2000; Liu et al., 
1998).  Once activated, PLC-γ cleaves phosphatidylinositol 4,5-bisphosphate to generate 
inositol 1,4,5-triphosphate (IP3) and diacylglycerol.  IP3 is responsible for initiating the 
release of intracellular Ca2+ from the endoplasmic reticulum (ER) by binding receptors on 
the ER membrane and opening Ca2+ release-activated Ca2+ (CRAC) channels (Lewis and 
Cahalan, 1995).  The rise in Ca2+ in combination with diacylglycerol activates protein 
kinase C (PKC) and is responsible for activating the phosphatase calcineurin, which 
dephosphorylates NFAT, resulting in its translocation to the nucleus where it is free to 
interact with members of the AP-1 family and initiate gene transcription (Jain et al., 
1995; Karin et al., 1997; Ullman et al., 1990). 
Knowledge of the signaling events emanating from the TCR after stimulation 
with agonist peptide has allowed researchers to assay a spectrum of peptide ligand-MHC 
pairs with known functional output (agonist, partial agonist, antagonist, and null) to 
determine if the TCR signaling events are differentially regulated by altered peptide 
ligands (APL).  Two independent groups found that agonist peptide induced two forms of 
phosphorylated TCR ζ monomers (p23 and p21), while partial agonist peptides only 
induced p21 phospho-ζ and partially bound non-activated ZAP-70 (Madrenas et al., 
1995; Sloan-Lancaster et al., 1994).  Formation of p21 phospho-ζ has also been reported 
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in response to antagonist peptides that show no agonist function at any concentration, 
providing evidence for TCR signaling without a typical activation response (Germain and 
Stefanova, 1999). 
In addition to the signals provided through the TCR, other surface molecules have 
been shown to impact the response of the T cell.  The most significant positive 
contributors to TCR signaling are the T cell co-receptors CD8 and CD4 as well as the 
costimulatory molecules CD28, CD27, 4-1BB (CD137), OX40 (CD134), CD30, 
herpesvirus entry mediator (HVEM), and glucocorticoid-induced TNF receptor (GITR) 
(Greenwald et al., 2005).  It has been proposed that the co-receptors function to stabilize 
the interaction between the TCR and MHC, as they bind MHC I and II molecules, 
respectively, and positively regulate the downstream signaling events (Gao et al., 2002).  
CD28 has also been shown to positively regulate downstream signaling events from the 
TCR by enhancing IL-2 production and IL-2R expression, and accelerating entry into the 
cell cycle (Acuto and Michel, 2003).  The costimulatory signals provided by CD28 are 
considered “signal 2” of TCR stimulation and are required for maximal activation of 
naïve T cells (Acuto and Michel, 2003).  In addition, cytokines such as IL-2, IFN-αβ, 
IFN-γ, and IL-12 are considered “signal 3” contributors to T cell activation and may or 
may not be required for CD8 T cell activation and memory generation under some 
infection conditions (Curtsinger et al., 2003; Curtsinger et al., 2005; Kolumam et al., 
2005; Thompson et al., 2006; Whitmire et al., 2007; Williams et al., 2006). 
 In addition to positive costimulation, there are a variety of negative feedback 
mechanisms in place to attenuate TCR signaling.  These negative signaling molecules 
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include Csk, CD45, c-Cbl, and CTLA-4.  Although these molecules have been shown to 
be of vital importance to the attenuation of T cell activation, none has been shown to play 
a role in the discrimination among peptide ligands that may result in different levels of 
activation.  In contrast to the inhibitory molecules above, the tyrosine phosphotase SHP-1 
has been linked to ligand discrimination.  The presence of SHP-1 in TCR complexes has 
been shown to be rapid for antagonist peptides, intermediate for partial agonists, and 
slowest for agonist peptides (Germain and Stefanova, 1999).  Thus, the engagement of 
antagonist or partial antagonist peptide-MHC is of sufficient duration and efficacy to 
yield the signals required for SHP-1 association with the TCR complex.  It appears that 
the slow association of SHP-1 to the TCR complex in response to agonist ligands is the 
result of ERK-1 binding to Lck and outcompeting SHP-1 for binding (Stefanova et al., 
2003). 
 
C.  Effector functions of virus-specific CD8 T cells 
 The signaling events emanating from the TCR (signal 1), costimulatory receptors 
(signal 2), and cytokine receptors (signal 3) culminate in the induction of a differentiation 
program to allow antigen-specific T cells to respond to the infectious pathogen.  The 
effector functions of CD4 and CD8 T cells are quite diverse and although of importance 
to the control of some pathogens, the functions of the effector CD4 T cell subsets will not 
be discussed further here.   
 The CD8 T cell response to acute viral infections can be divided into three distinct 
phases: expansion, contraction, and memory.  The expansion phase is so named because 
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the virus-specific CD8 T cells undergo rapid and robust division.  Studies have estimated 
approximately one division every 6 hours and as many as 15 or more divisions per cell, 
resulting in a dramatic rise in CD8 T cell number (Masopust and Ahmed, 2004; Masopust 
et al., 2007; Murali-Krishna et al., 1998).  Following the clearance of the pathogen, most 
of the virus-specific CD8 T cells undergo apoptosis during the contraction phase.  Some 
virus-specific CD8 T cells survive contraction and develop into memory CD8 T cells to, 
along with CD4 T cell and B cell memory, provide the host with lifelong immunity to the 
infecting pathogen. 
 Naïve CD8 T cells start to divide approximately 20 hours after antigen contact 
(Zimmermann et al., 1999).  Prior to the onset of division, newly activated T cells up-
regulate the transcription of cyclin D and G1 genes (Teague et al., 1999).  After the onset 
of division, T cells have also up-regulated transcription of cyclins A1, B, and E (Teague 
et al., 1999).  Conversely, some proteins that are involved in suppressing cell division, 
such as the retinoid acid receptor (RAR) and the proliferation inhibitors D52, TGF-β-
stimulated clone 22 (TSC-22), and cyclin-dependent kinase inhibitors (CDKi) p27 and 
p21 are down-regulated in activated T cells (Grayson et al., 2001; Teague et al., 1999).  
The expression of molecules involved in the cell cycle is tightly regulated, and the altered 
expression after TCR stimulation allows for the newly activated T cells to divide very 
rapidly. 
 Concomitant to the expansion phase and rapid proliferation, the virus-specific 
CD8 T cells differentiate into effector CD8 T cells (also known as cytotoxic T 
lymphocytes or CTL).  This process does not require sustained antigen presentation, 
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indicating that the initial TCR priming from the peptide-MHC is sufficient to program the 
differentiation of the parental CD8 T cell, which instructs the daughter cells to continue 
dividing and differentiating (Kaech and Ahmed, 2001). The differentiation of naïve CD8 
T cell to CTL is associated with large-scale changes in chromatin structure, gene 
expression, membrane structure, migratory potential, survival, self-renewal, and effector 
functions (Kaech et al., 2002).   
 Gene expression profiling studies have demonstrated enhanced transcription of 
adhesion molecules (galectin-3, P-selectin ligand, CD11c), trafficking molecules 
(CXCR4, CCR2, CCR5), and cytoskeletal proteins (filamin, talin) that ultimately lead to 
migration of virus-specific CTL to infected peripheral tissues (Kaech et al., 2002; Teague 
et al., 1999).  In addition to expression of proteins required for migration, virus-specific 
CTL also up-regulate effector molecules that allow them to combat the virus and lyse 
virus-infected cells.  Some of these molecules are cytokines and chemokines such as IFN-
γ, TNF, MIP-1β, and Rantes, while some are molecules involved in cytolytic activity 
such as granzymes, perforin, and Fas ligand (Carding et al., 1993; Grayson et al., 2001; 
Kaech et al., 2002; Teague et al., 1999).  Cytokine production and cytolytic activity make 
up the two arms of CTL effector functions and play complementary roles in controlling 
virus infections (Slifka and Whitton, 2000). 
 Cytolytic ability of CTL can be acquired after one cell division, and efficiency of 
cytolysis has been shown to increase with subsequent divisions (Oehen and Brduscha-
Riem, 1998).  In another study, enhanced cytolytic ability correlated with the increased 
expression of perforin and granzymes in CTLs that had undergone 6-8 divisions 
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compared to those CTL that had undergone only 3 divisions (Jenkins et al., 2008).  
Effector CTL are able to rapidly lyse virus-infected cells; one study has shown that nearly 
100% of peptide-pulsed target cells are eliminated within an hour after transfer into 
lymphocytic choriomeningitis virus (LCMV)-infected mice at the peak of the CTL 
response (Barber et al., 2003).  Memory CD8 T cells retain the ability to quickly lyse 
infected cells within 4 hours, and if these experiments are normalized to the frequency of 
peptide-specific CTL, effector and memory CD8 T cells have similar (within 2-fold) lytic 
ability (Barber et al., 2003; Ganusov and De Boer, 2008; Regoes et al., 2007; Yates et al., 
2007).   
  A lot of work has focused on the regulation of effector molecule expression by 
CTL, as its dysregulation could be detrimental to the host and result in immune-
pathology.  Naïve CD8 T cells require approximately 3 days to start transcribing IFN-γ, 
while effector and memory CTL retain the ability to turn on IFN-γ transcription very 
rapidly (Aune et al., 1997; Zimmermann et al., 1999).  The rapidity with which virus-
specific CTL can express IFN-γ increases with time as the cells differentiate into memory 
(Liu et al., 2004).  Upon removal of specific peptide antigen, CTL rapidly turn off 
expression of IFN-γ (Slifka et al., 1999).  Since cytokine mRNAs are notoriously 
unstable, the cessation of transcription results in a rapid decline in IFN-γ protein available 
to secrete (Sachs, 1993; Slifka et al., 1999).  Restimulation with peptide results in rapid 
transcription of IFN-γ that can reach initial levels within 1 hour (Slifka et al., 1999).  
Importantly, in vivo virus-specific CTL are not continuously producing IFN-γ, but retain 
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the ability to turn on its expression when re-encountering antigen, potentially in a local 
environment of infected tissue (Liu and Whitton, 2005). 
 IFN-γ transcription can be regulated by the chromatin accessibility of the locus 
and the expression of transcription factors.  In naïve CD8 T cells, the IFN-γ locus is 
highly methylated and in a closed, condensed conformation, which inhibits transcription 
of the gene (Kersh et al., 2006; Northrop et al., 2006; Zhou et al., 2004).  After activation, 
the IFN-γ locus is unmethylated, acetylated, and the chromatin opens up to allow access 
to the transcriptional machinery (Fitzpatrick et al., 1998; Kersh et al., 2006; Northrop et 
al., 2006; Zhou et al., 2004).  In memory CD8 T cells, the IFN-γ locus remains acetylated 
and in an open conformation, but it is methylated.  Following restimulation, the IFN-γ 
locus is rapidly unmethylated to allow access to the transcriptional machinery and 
subsequent transcription (Kersh et al., 2006).  Interestingly, forced histone acetylation of 
the IFN-γ locus by chemical inhibitors of deacetylases induces IFN-γ transcription under 
conditions in which the T cells produce very little IFN-γ (Northrop et al., 2008).  Stable 
epigenetic changes at the IFN-γ locus play a key role in keeping memory CD8 T cells 
poised to rapidly respond to reencounter with antigen.  It is likely that stable epigenetic 
modifications at multiple loci involved in survival, metabolism, proliferation, and 
effector functions occur in memory CD8 T cells (Pearce and Shen, 2006). 
 Another layer of regulation is the expression of transcription factors that drive the 
transcription of the effector molecules IFN-γ, granzymes, and perforin.  The transcription 
of effector molecule genes are regulated by a variety of transcription factors including T-
bet, Eomesodermin (Eomes), cyclic AMP-responsive-element-binding protein 1 
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(CREB1), activating transcription factor (ATF) 1 and 2, JUN, OCT1, signal transducer 
and activator of trascription 1 (STAT1), STAT4, runt-related transcription factor 3 
(RUNX3), and REL.   
 The T box transcription factors T-bet and Eomes are the principle transcription 
factors in the regulation of IFN-γ transcription by virus-specific CD8 T cells (Intlekofer 
et al., 2008; Intlekofer et al., 2005; Mayer et al., 2008; Sullivan et al., 2003).  The 
expression of these transcription factors is low in naïve CD8 T cells, and they are both 
up-regulated in effector CTL, with T-bet being the prominent transcription factor present 
(Cruz-Guilloty et al., 2009; Takemoto et al., 2006).  Eomes, in contrast, is up-regulated 
further in memory CD8 T cells (Takemoto et al., 2006).  Knockout and knockdown 
studies of both transcription factors have revealed partially overlapping and 
compensatory functions in CD8 T cells (Intlekofer et al., 2007; Intlekofer et al., 2005; 
Mayer et al., 2008; Pearce et al., 2003; Sullivan et al., 2003).  Due to partially redundant 
functions, CD8 T cells lacking both transcription factors have the most pronounced 
defect in effector functional capabilities.  LCMV-specific CD8 T cells lacking T-bet and 
Eomes express very little IFN-γ, perforin, and GrzB and instead express an aberrantly 
high amount of IL-17 (Intlekofer et al., 2008). 
 As a secreted factor, IFN-γ can induce a wide range of responses.  IFN-γ signals 
through the IFN-γ receptor (IFN-γR) that induces the activation of Janus kinase 1 and 2 
(Jak1, 2) and subsequent phosphorylation of STAT1 (Bach et al., 1997; Schindler, 1999).  
Activated STAT dimers translocate to the nucleus and transactivate genes with gamma-
activated sequences (GAS) and in some cases IFN-stimulated response elements (ISRE).  
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NFκB and c-Jun have also been identified as transcription factors activated during IFN-γ 
signaling and some STAT1-independent genes have also been identified (Ramana et al., 
2002).  IFN-γ, like IFN-αβ, can induce the upregulation of MHC.  However, IFN-γ is 
much more potent at upregulating MHC II expression (Boehm et al., 1997).  IFN-γ is also 
a potent activator of macrophages by specifically inducing the production of nitric oxide 
sythase, whose product, nitric oxide, plays an important role in the host response against 
microbial and viral pathogens (Nathan, 1997). 
  
D.  Generation and maintenance of memory CD8 T cells 
 Following clearance of the virus, most of the virus-specific CD8 T 
 cells undergo apoptosis during the contraction phase, but some virus-specific T cells 
survive contraction, differentiate into memory, and provide the host with immunity to the 
virus.  There are certain surface receptors expressed on effector CD8 T cells during the 
acute phase of the immune response that have been associated with the ability to survive 
the contraction phase and to generate memory.  These markers include IL-7Rα (CD127) 
and killer cell lectin-like receptor 1 (KLRG1).  Virus-specific CTL that retain high 
expression of IL-7Rα and do not up-regulate KLRG1 have a longer lifespan and can 
proliferate well in response to homeostatic cytokines and antigen, thus have the highest 
capacity to develop into memory T cells (referred to as memory precursor effector cells 
(MPEC)).  In contrast, those T cells that have down-regulated IL-7Rα and up-regulated 
KLRG1 have a shorter lifespan and reduced proliferative capacity and are thus more 
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terminally differentiated (referred to as short-lived effector cells (SLEC)) (Huster et al., 
2004; Joshi et al., 2007; Kaech et al., 2003; Sarkar et al., 2008).   
Although it is not clear exactly how or when virus-specific effector CD8 T cells 
differentiate into memory cells, it is clear that specific signals during the initial priming 
of naïve T cells are required for the generation and maintenance of functional memory 
CD8 T cells.  Some of these requirements include the signal 3 cytokines IFN-αβ and/or 
IL-12 and IL-2 provided by CD4 T cells (CD4 help) (Curtsinger et al., 2005; Thompson 
et al., 2006; Williams et al., 2006).  Inflammation can also impact memory development 
by inducing expression of T-bet and driving a SLEC fate (Joshi et al., 2007), and a lack 
of inflammation during T cell activation, via DC immunization, results in the rapid 
acquisition of memory characteristics (Badovinac et al., 2005).   
Memory CD8 T cells can be divided into two subsets, central (TCM) and effector 
(TEM) based on anatomical location, proliferative capacity, and effector functions.  TCM 
express the lymph node homing molecules CD62L and CCR7 and have a higher 
proliferative capacity, while TEM lack expression of these molecules, reside in 
nonlymphoid tissues, and have been shown to acquire effector functions such as cytolysis 
more rapidly (Masopust et al., 2001; Sallusto et al., 1999; Wherry et al., 2003).  There is 
a linear relationship between these two memory subsets, as TEM can convert to TCM 
(Wherry et al., 2003).  Thus TCM are true memory T cells with the ability to self-renew 
and proliferate in response to secondary challenge. 
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E.  Susceptibility of T cells to cell death during the acute immune response 
 During the acute immune response to LCMV, T cells are susceptible to cell death 
in three distinct phases, which serve to maintain the homeostasis of the T cell repertoire 
for further antigenic challenges.  These phases are distinguished kinetically throughout 
the immune response and by mechanisms of induction.  The first phase is a IFN-αβ-
dependent attrition of memory T cells that occurs 2-4 days post infection (McNally et al., 
2001).  The second phase is a susceptibility of both highly activated virus-specific CD8 T 
cells and bystander CD8 T cells to activation-induced cell death (AICD) mediated by 
repeated TCR stimulation and Fas-FasL interactions (Razvi and Welsh, 1993; Zarozinski 
et al., 2000).  The final phase is activated cell autonomous cell death (ACAD) that is 
responsible for the contraction of the immune response mediated by a Bcl2-interacting 
molecule (Bim)- and p53 up-regulated modulator of apoptosis (Puma)-dependent cell 
death pathway initiated by cytokine withdrawal (Erlacher et al., 2006; Krammer et al., 
2007; Razvi and Welsh, 1995). 
 Infection of mice with LCMV induces a profound IFN-αβ response early after 
infection, and this IFN-αβ has been shown to be required for maximal expansion of 
LCMV-specific T cells (Aichele et al., 2006; Kolumam et al., 2005; Quigley et al., 2008; 
Thompson et al., 2006).  The IFN-αβ that is induced early after infection is also required 
for the early deletion of memory phenotype (CD44hi) T cells that precedes the expansion 
of virus-specific T cells (Jiang et al., 2005; McNally et al., 2001).  Both virus-specific 
and bystander T cells are susceptible to this IFN-αβ-induced attrition (Bahl et al., 2006).  
The loss of memory T cells may allow for a more diverse T cell response by diminishing 
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the frequency of potentially cross-reactive memory cells, which could otherwise 
dominate the response (Bahl et al., 2006) (Bahl et al., manuscript in preparation).  The 
IFN-αβ-dependent apoptosis of T cells requires the pro-apoptotic BH3-only Bcl-2 family 
member Bim and may also involve the TNF receptor superfamily member Fas (Bahl et 
al., manuscript in preparation).  These two molecules are members of different apoptotic 
pathways, but have also been shown to converge during the contraction of the immune 
response to LCMV (Weant et al., 2008). 
 Naïve CD8 T cells are relatively resistant to apoptosis, but effector CTL are 
highly susceptible to AICD.  During the acute phase of LCMV infection, virus-specific 
CTL downregulate Bcl-2 while simultaneously upregulating Bax and Bad, inducing a 
pro-apoptotic state (Grayson et al., 2001).  Activated T cells also downregulate a negative 
regulator of Fas signaling, FLICE-like inhibitory protein (FLIP) allowing them to be 
more sensitive to Fas-induced apoptosis (Algeciras-Schimnich et al., 1999; Irmler et al., 
1997).  Highly activated virus-specific CD8 T cells upregulate the death domain 
containing receptors Fas and TNFR p55 and p75 (Miyawaki et al., 1992; Ryffel and 
Mihatsch, 1993).  Activated T cells can undergo AICD via ligation of FasL, TNF, or 
TRAIL (Hildeman et al., 2002b). In addition, in highly activated T cells, hematopoietic 
progenitor kinase 1 (HPK1) gets cleaved by active caspase 3 (Chen et al., 1999).  The C 
terminal domain of HPK1 blocks NFκB activation, thus inhibiting cell survival and 
promoting cell death (Arnold et al., 2001; Brenner et al., 2005).   
 In addition to highly activated virus-specific CTL, naïve bystander CD8 T cells 
have also been shown to be susceptible to AICD if they get stimulated through their TCR 
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in vitro (Zarozinski et al., 2000).  During an acute immune response, virus-specific CTL 
up-regulate FasL in order to engage Fas on, and subsequently lyse, virus-infected cells.  
FasL expression on virus-specific CTL was necessary for the AICD of TCR-stimulated 
bystander CD8 T cells and suggests that the up-regulation of Fas on newly activated non-
virus-specific CD8 T cells may direct them down a death pathway instead of a survival 
and proliferative pathway.  The susceptibility of bystander CD8 T cells to AICD could 
contribute to virus-induced immune suppression by inhibiting the development of a new 
T cell response to a superinfecting pathogen during an ongoing immune response. 
 Following clearance of the viral infection, most virus-specific CTL will undergo 
ACAD during the contraction phase of the immune response.  Apoptosis of virus-specific 
CTL during the contraction phase is only minimally due to AICD, as T cells deficient in 
Fas, FasL, or other TNFSF receptors that can induce apoptosis undergo relatively normal 
contraction (Lohman et al., 1996; Razvi et al., 1995; Reich et al., 2000; Weant et al., 
2008).  The mechanisms that control whether a virus-specific CD8 T cell survives or 
undergoes ACAD during the contraction phase are not well characterized, but there are 
several factors that have been shown to play a role in this cell fate decision.   
 Cytokine withdrawal during the acute immune response is thought to play a role 
in initiating ACAD.  Cytokines of the common γ-chain family, including IL-2, IL-7, and 
IL-15 have been shown to modulate CD8 T cell survival and proliferation.  Due to the 
expression of IL-2 and the high affinity IL-2Rα chain (CD25) initiated by antigen, IL-2 
signaling is thought to potentially augment T cell programming and play a role in 
memory potential.  In vivo, IL-2 enhances but is not essential for CD8 T cell expansion.  
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Moreover, CD8 T cells deficient in CD25 expand and contract normally, but develop into 
poor memory cells (Williams et al., 2006).  Enhancing and/or maintaining IL-2 signaling 
can prevent the contraction of virus-specific T cells, and removal of IL-2 results in rapid 
T cell apoptosis back down to homeostatic levels (Blattman et al., 2003).  IL-7 is also 
thought to play a role in memory differentiation because virus-specific CD8 T cells that 
retain high expression of IL-7Rα were shown to have an enhanced ability to generate 
memory cells (Kaech et al., 2003).  Although expression of the IL-7Rα chain is necessary 
for the survival of memory T cells, its expression is not sufficient to force the survival of 
effector CD8 T cells during contraction (Hand et al., 2007).  IL-15 has also been shown 
to play an important role in the survival of memory T cells, but it appears to be more 
important for the homeostatic division and maintenance of memory cells rather than their 
establishment (Becker et al., 2002; Judge et al., 2002). 
 The withdrawal of cytokine signaling induces stress within activated T cells that 
results in the activation of pro-apoptotic molecules of the BH3-only Bcl-2 protein family 
including Bim and Puma.  In the steady state, anti-apoptotic Bcl-2-like proteins (Bcl-2, 
Bcl-xL, Mcl-1) neutralize the pro-apoptotic BH3-only proteins  (Bim, Puma, Noxa, Bad, 
Bmf, Bik, Bid) via heterodimeric interactions (Cheng et al., 2001).  After activation, T 
cells downregulate Bcl-2 (Grayson et al., 2001), thus freeing the pro-apoptotic proteins.  
Free BH3-only proteins, such as Bim and Puma, bind Bax-like proteins  (Bax, Bak, Bok) 
on the mitochondrial membrane and initiate cytchrome c release and downstream 
apoptosis (Martinou and Green, 2001). 
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 Bim deficiency delays the contraction of LCMV-specific CD8 T cells and results 
in enhanced accumulation of memory CD8 T cells (Pellegrini et al., 2003; Weant et al., 
2008; Wojciechowski et al., 2006).  The accumulation of memory CD8 T cells can be 
enhanced further by blocking ACAD and AICD via combined deficiencies of Bim and 
Fas (Weant et al., 2008).  Apoptosis requires the downregulation of Bcl-2 in activated T 
cells as overexpression of Bcl-2 can rescue cytokine withdrawal-mediated apoptosis of T 
cells in vitro (Erlacher et al., 2006; Strasser et al., 1991) and T cell contraction in 
response to superantigen in vivo (Hildeman et al., 2002a).  Further, Bcl-2 overexpression 
or Bim deficiency rescues the development and function of T cells in IL-7Rα knockout 
and common γ chain knockout mice (Akashi et al., 1997; Kondo et al., 1997; 
Maraskovsky et al., 1997; Pellegrini et al., 2004).  The enhanced survival of T cells 
lacking Bim is abrogated in T cells lacking both Bim and Bcl-2, suggesting that the 
survival initiated by the loss of Bim depends on the presence of Bcl-2 (Wojciechowski et 
al., 2007).  It should be noted that Bcl-2 overexpression does not always rescue the 
contraction of activated T cells, particularly following LCMV infection (Petschner et al., 
1998; Razvi et al., 1995). This may be due to a role for Fas in the contraction of LCMV-
specific T cells (Weant et al., 2008) and suggests that under some infection conditions, 
particularly ones that initiate multiple apoptotic pathways, Bcl-2 overexpression cannot 
inhibit contraction.  This issue is further clouded by the recent retractions of a series of 
publications by Luke van Parijs and thus more work is needed to clarify the role of Bcl-2 
during T cell contraction. 
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 In addition to Bim, another BH3-only Bcl-2 family protein, Puma also plays a 
role in the contraction of T cell responses, as Puma deficient T cells accumulate after 
HSV infection, albeit not to the extent of Bim deficient T cells (Fischer et al., 2008).  In 
support of the combined roles of Bim and Puma, double deficiency of both molecules 
results in enhanced survival of activated T cells after cytokine withdrawal in vitro 
(Erlacher et al., 2006).  The enhanced survival of Bim and Puma double deficient T cells 
is less than Bcl-2 overexpressing transgenic T cells in this experimental system, 
suggesting that additional BH3-only proteins may also contribute to cytokine withdrawal-
mediated apoptosis of T cells (Erlacher et al., 2006).  Thus, CD8 T cell contraction 
following pathogen clearance is mediated by the pro-apoptotic activities of Bim, Puma, 
and perhaps other BH3-only proteins, but can be overridden, under some conditions, by 
the anti-apoptotic effects of Bcl-2. 
 
F.  Arenaviridae    
 The prototype virus in the arenaviridae family is LCMV, which has been used 
extensively in the laboratory for the study of anti-viral immune responses in mice and 
most of the research discussed in sections C & D was generated using this viral system.  
Studies using LCMV have contributed to many fundamental immunological concepts 
including immunological tolerance, virus-induced immune-pathology, MHC restriction, 
NK cell activation, immune deficiency, autoimmunity, immunological memory, and 
cellular immunity (Welsh, 2000).  Two Nobel prizes have been awarded to investigators 
based on studies that utilized LCMV.   
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Members of the virus family arenaviridae are natural rodent viruses that cause 
asymptomatic persistent infections in their rodent hosts.  There are currently 18 known 
species of arenaviruses, which are divided into two antigenic groups based on serology.  
Old World arenaviruses include LCMV, Lassa fever virus, and Mopeia virus.  New 
World arenaviruses include Machupo virus, Junin virus, and Pichinde virus (PV).  
Despite their natural rodent hosts, some arenaviruses such as Junin and Lassa fever can 
cause severe hemorrhagic diseases in humans (Frame et al., 1970; Johnson et al., 1965; 
Salas et al., 1991), and it is reported that LCMV could account for about 8% of 
nonbacterial meningitis in North America (Adair et al., 1953; Meyer et al., 1960). 
Arenaviruses are enveloped, pleomorphic spheres ranging in size from 50-300 nm 
in diameter and are granular in appearance due to the presence of ribosomes (Welsh, 
2000).  Virions contain a bi-segmented ambisense RNA genome consisting of small (S) 
and large (L) segments (Auperin et al., 1984b; Pedersen, 1973; Ramsingh et al., 1980).  
The S segment is approximately 3,500 nucleotides and encodes the nucleoprotein (NP) 
and the envelope glycoproteins (GP1 and GP2) (Auperin et al., 1984a; Clegg et al., 1991; 
Wilson and Clegg, 1991).  The L segment is roughly 7,100 nucleotides and encodes the 
viral polymerase (L) and the Z protein (Iapalucci et al., 1989a; Iapalucci et al., 1989b; 
Salvato et al., 1989; Salvato et al., 1992; Singh et al., 1987). Due to the ambisense 
orientation of the genome, NP and L mRNAs are transcribed directly from the RNA 
genome, while GP and Z mRNAs are transcribed from negative sense anti-genome 
regions (Auperin et al., 1984a; Auperin et al., 1984b). 
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 The NP is a 60-68 kd protein and is the major structural protein in the 
nucleocapsids of arenavirions (Bruns et al., 1986).  The GP is transcribed as a polyprotein 
that is post-translationally cleaved into GP1 and GP2 (Buchmeier et al., 1987; Wright et 
al., 1990).  GP1 is a 40-46 kd protein that is responsible for binding to the cellular 
receptor, while GP2 is a 35 kd protein that serves as the fusion protein.  GP1 and GP2 
oligomerize to form tetrameric spikes on the enveloped membrane to facilitate binding 
and fusion to target cells.  The L protein is 180-250 kd and serves as an RNA-dependent 
RNA polymerase that is required for viral replication (Salvato et al., 1989; Sanchez and 
de la Torre, 2005).  The Z protein is the smallest viral protein at 11 kd and has recently 
been reported to be required for viral budding (Perez et al., 2003; Strecker et al., 2003).  
The GP1 encoded by Old World arenaviruses and clade C of the New World viruses 
binds to the ubiquitous cellular glycoprotein alpha-dystroglycan, which allows for wide 
host range and tissue infectivity (Borrow and Oldstone, 1992, 1994; Cao et al., 1998; 
Spiropoulou et al., 2002).  Despite wide tissue infectivity, LCMV Armstrong strain 
replicates predominantly within lymphoid tissues, while other strains such as WE 
demonstrate a wider target range.  Macrophages have been identified as an early and 
prominent cell type infected, followed by infection of epithelial cells and marginal zone 
and follicular cells of secondary lymphoid tissues. 
 There are currently three predominant strains of LCMV used in the laboratory to 
study anti-viral immunity: Armstrong, Traub, and WE.  The Armstrong strain was 
isolated from a monkey inoculated with a serial passage of cerebrospinal fluid from a 
suspected human case of St. Louis encephalitis virus (Armstrong C, 1934).  
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Subsequently, Eric Traub isolated a serologically identical virus from a persistently 
infected mouse colony (Traub, 1935), while WE virus was isolated from an employee 
(initials W.E.) exposed to Traub’s mouse colony that presented with a fatal hemorrhagic 
disease (Scott, 1936).  
 Some isolates of LCMV such as Armstrong clone 13 and WE docile cause 
immune suppression in immuno-competent adult mice (Ahmed et al., 1984; Pfau et al., 
1982).  These virus strains have been used extensively to study the concept of clonal 
exhaustion, whereby high doses of viral antigen drive the loss of function and eventual 
deletion of virus-specific T cells, a phenomenon that may be shared among some chronic 
viral infections.  The Armstrong clone 13 strain only differs from its parental strain by 
two amino acids, one in the L protein and one in the GP1 protein (Matloubian et al., 
1990; Salvato et al., 1991).  The GP1 mutation has been shown to confer broader cell 
tropism and enhanced affinity for the alpha-dystroglycan receptor, while the L mutation 
confers enhanced replication (Matloubian et al., 1993).  Thus, these combined mutations 
result in increased infectivity and generation of more viral progeny, perpetuating the 
increased viral titers that lead to T cell exhaustion. 
 In addition to its use in T cell exhaustion studies, LCMV clone 13 is also the virus 
used in the congenitally infected LCMV carrier mouse model.  These mice are infected in 
utero by using persistently infected female mice as breeders.  Infection with LCMV in 
utero results in the development of an LCMV-tolerant immune system and persistent 
viral replication throughout the life of the mice (King et al., 1992).  This model has been 
used to study the concepts of tolerance and bystander T cell activation (see section J). 
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G.  Innate type I IFN (IFN-αβ) response to arenavirus infections 
 Infection of wild type mice with LCMV Armstrong induces a rapid and prominent 
IFN-αβ response (Merigan et al., 1977; Welsh, 1978) possibly due to the recognition of 
viral RNAs by toll-like receptors (TLRs) and/or retinoic acid-inducible gene (RIG)-I-like 
receptors (RLRs).  TLR 3, 7, and 8, MDA5 and RIG-I are RNA sensors (Alexopoulou et 
al., 2001; Diebold et al., 2004; Heil et al., 2004; Lund et al., 2004; Yoneyama et al., 
2005) that recognize various forms, lengths, structures, and sequences of RNA to 
distinguish among viral and cellular RNAs (Kato et al., 2008; Marques et al., 2006; 
Yoneyama et al., 2004).  Depending on the RNA intermediates generated during 
replication, the subcellular location of viral RNA, and the expression of TLRs and RLRs 
in infected cells, different viruses can be recognized by different TLRs and RLRs (Kato 
et al., 2006; Kumar et al., 2006; Loo et al., 2008; Melchjorsen et al., 2005). 
 Signaling through TLRs and RLRs by viral RNA results in the activation of the 
IKKα/β/γ complex and mitogen activated protein kinase (MAPK) cascades, which lead 
to the activation of NF-κB, AP-1, and TANK-binding kinase 1 (TBK1) (Figure 1.2).  
Active TBK1 phosphorylates the interferon regulatory factors (IRF) 3 and 7, which 
homo- and hetero-dimerize and translocate to the nucleus (Fitzgerald et al., 2003; Lin et 
al., 2000; Sharma et al., 2003).  IRF3/7 homo- and hetero-dimers interact with the CREB-
binding protein (CBP) and promote transcription of the type I IFNs: IFN-α and IFN-β 
(Sato et al., 1998b; Suhara et al., 2000; Yoneyama et al., 1998).  In the steady state, IRF3 
is constitutively expressed, while IRF7 is expressed at relatively low levels (Marie et al., 
1998; Sato et al., 1998a).  The result of this expression profile is that upon TLR or RLR  
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Figure 1.2.  Intracellular nucleic acid sensors and signaling pathways.   
(Gilliet et al., 2008) 
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stimulation, most of the phosphorylated IRF forms are IRF3/3 homodimers and few 
IRF3/7 heterodimers.  IRF3/3 homodimers potently transactivate the IFN-β and IFN-α4 
genes (Sato et al., 1998b).  Signaling of IFN-β and IFN-α4 through the heterodimeric αβ 
IFN-I receptor (IFN-αβR) activates the interferon-stimulated gene factor 3 (ISGF3) 
complex composed of IRF9, STAT1, and STAT2 that is responsible for the induction of 
IRF7 transcription (Marie et al., 1998; Sato et al., 1998a).  The increased expression of 
IRF7 results in the production of phosphorylated IRF7/7 homodimers in response to 
further TLR or RLR stimulation and transactivation of the IFN-β and IFN-α1,2,4,5,6, and 
8 genes, which potentiates further increased IFN-αβ production in a positive feedback 
loop (Marie et al., 1998; Sato et al., 1998a; Sato et al., 2000). 
 Although many virus-infected cells are capable of producing IFN-αβ, 
plasmacytoid (pDC) and conventional dendritic cells (cDC) are the primary IFN-αβ 
producers in response to viral infections (Cella et al., 1999; Diebold et al., 2003).  DCs 
are also a prominent cell type infected by arenaviruses, providing a mechanism for the 
strong induction of IFN-αβ by LCMV.  It has not yet been determined which specific 
TLRs and/or RLRs recognize arenavirus RNAs, but it is clear that signaling through these 
receptors plays an important role in the induction of IFN-αβ, the generation of a strong 
CD8 T cell response, and the proper control of the virus, as shown by infection of mice 
lacking the TLR adapter protein MyD88 (Jung et al., 2008; Rahman et al., 2008; Zhou et 
al., 2005).  TLR3 and 7/9 are probably not the sole LCMV RNA sensors, as mice 
deficient in TLR3 or TLR7 and 9 mount normal LCMV-specific T cell responses  
(Edelmann et al., 2004; Jung et al., 2008).  Mice deficient in the RLR adaptor protein 
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MAVS also mount normal LCMV-specific CD8 T cell responses, indicating that RIG-I 
and MDA5 might not be responsible for LCMV RNA detection (Jung et al., 2008).  It is 
also important to note that the induction of IFN-α and IFN-β may be differentially 
regulated by TLR and RLR pathways, as mice deficient in TLR7/9 can induce IFN-β but 
not IFN-α in response to LCMV (Jung et al., 2008).  It is likely that multiple mechanisms 
and potentially unknown RNA sensors and/or pathways exist to detect arenaviral RNAs 
and that blockade or deficiency in any one pathway may not completely abrogate IFN-αβ 
induction. 
 The synthetic dsRNA analog polyriboinosinic:polyribocytidylic acid (poly(I:C)) 
has been used extensively in the laboratory to mimic viral dsRNA induction of IFN-αβ 
and will also be used in this study.  Poly(I:C) is detected primarily by MDA5 as MDA5 
deficiency, but not TLR3 or RIG-I deficiency, abrogates the induction of IFN-αβ 
following stimulation with poly(I:C) (Gitlin et al., 2006; Kato et al., 2006).    
 As a secreted factor, IFN-αβ plays a role in regulating a multitude of immune 
responses via signaling through the IFN-αβR and leading to the transcription of hundreds 
of IFN-stimulated genes (ISG), including amplification of more and different IRFs to 
drive further transcription of IFN-αβ in the positive feedback loop described above.  In 
mammals, there is one IFN-β gene and thirteen IFN-α genes whose transcription is 
regulated by the expression of various IRFs, of which there are nine members, that bind 
to ISRE sequences in ISG promoters.  Some ISGs are antiviral genes such as protein 
kinase R (PKR), 2’-5’ oligoadenylate synthetase (OAS), adenosine deaminase (ADAR), 
and the GPTase Mx.  Others are involved in IFN signaling, such as STAT proteins and 
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IRFs, and there are also many ISGs with as yet unidentified functions (Samuel, 2001; Sen 
and Sarkar, 2007). 
 As its name implies, IFN-αβ can directly interfere with viral replication, but it 
also has pleiotropic effects on a variety of cells in the immune system.  IFN-αβ has been 
shown to mature DCs, promote Th1 cytokine production from CD4 T cells, and activate 
NK cells (Krug et al., 2003; Way et al., 2007; Welsh, 1978).  IFN-αβ has also been 
implicated in driving the apoptosis of memory T cells early after viral infection.  IFN-αβ 
also has pleiotropic effects on T cells, as it supports effector the differentiation, 
proliferation, and survival of activated T cells, while inhibiting the proliferation of naïve 
T cells.  Direct signaling of IFN-αβ via STAT1 in CD8 T cells is required for the 
maximal expansion of virus-specific T cells during acute infection with LCMV (Aichele 
et al., 2006; Kolumam et al., 2005; Quigley et al., 2008; Thompson et al., 2006).  
 
H.  T cell response to arenavirus infections 
 The CD8 T cell response to LCMV infection in mice has been extensively 
characterized.  Despite the multiple effector functions of CTLs and the dependence on 
virus-specific CTL for clearance of LCMV, viral clearance only requires a CTL response 
with functional cytolytic activity via perforin (Fung-Leung et al., 1991; Kagi et al., 1994).  
Infection of C57BL/6 mice with LCMV induces a reproducible and potent H2b-restricted 
CD8 T cell response.  The CD8 T cell response may be so large because LCMV does not 
inhibit MHC class I antigen presentation, and it induces a strong IFN-αβ response, both 
of which enhance CD8 T cell activation and proliferation (Bukowski and Welsh, 1985; 
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Kolumam et al., 2005).  CD8 T cells from C57BL/6 mice can recognize at least 20 
LCMV-encoded peptides (Kotturi et al., 2007; van der Most et al., 1998).  GP33/34- and 
NP396-specific CD8 T cells co-dominate the response, followed by sub-dominant 
responses of L455, GP44, GP276, L349, and others (Table 1.1).  During the acute phase of the 
immune response, GP33/34- and NP396-specific CD8 T cells comprise as much as a third of 
the overall CD8 T cell response, while the subdominant epitope-specific CD8 T cell pool, 
of ~20 or more specificities, make up the rest.  These responses can be detected by a 
number of assays, including the expression of IFN-γ and TNF after in vitro restimulation 
and direct staining with MHC H2b-peptide multimeric complexes.  Less well studied is 
the CD8 T cell response of C57BL/6 mice infected with PV.  There are four described H-
2b CD8 T cell epitopes NP38, NP122, NP16, and NP205 (Brehm et al., 2002) (Table 1.2).  
The NP38 response is dominant, followed by subdominant responses of the others, and 
there are as of yet no described CD4 T cell epitopes. 
 
I.  Transient virus-induced immune suppression 
 Many virus infections induce a transient state of immune suppression that can be 
measured by reduced T cell responses in vitro to mitogens or specific recall antigens and 
by diminished delayed-type hypersensitivity (DTH) responses in vivo to antigens such as 
tuberculin (Kantzler et al., 1974; Mims and Wainwright, 1968; Welsh et al., 1995).  
Although some viruses encode proteins to inhibit various phases of the immune response, 
many do not.  The diverse natures of the many viruses that induce immune suppression 
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Table 1.1.  H2b (B6) CD8 T cell epitopes in LCMV1 
Epitope aa sequence MHC  restriction 
Immuno-
dominance 
NP396 FQPQNGQFI Db  
GP33 KAVYNFATC Db  
GP34 AVYNFATC Kb  
L455 FMKIGAHPI Db  
GP44 FALISFLLL Db  
GP276 SGVENPGGYCL Db  
L349 SSLIKQSKF Kb  
L689 KFMLNVSYL Db  
L2062 RSIDFERV Kb  
NP205 YTVKYPNL Kb  
L1369 FAAEFKSRF Kb  
L156 ANFKFRDL Kb  
GP118 ISHNFCNL Kb  
NP165 SLLNNQFGTM Db  
NP238 SGYNFSLGAAV Kb  
GP221 SQTSYQYL Kb  
L1878 GPRQSFVS Kb  
 
 
Table 1.2.  H2b (B6) CD8 T cell epitopes in PV1 
Epitope aa sequence MHC  restriction 
Immuno-
dominance 
NP38 SALDFHKV Kb  
NP122 VYEGNLTNTQL Db  
NP16 RGLSNWTHPV Db  
NP205 YTVKFPNM Kb  
  
                                                
1 Epitope designation (gene and start site), amino acid sequences, and T cell MHC 
restriction are listed in order of relative immunodominance.  Only epitopes generating 
~2% or more of the CD8 T cell response are listed. 
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suggests broad and possibly host-regulated mechanisms.  In fact, in several acute and 
persistent viral infections the failure of T cells to proliferate in response to these mitogens 
or antigens in vitro has been linked to the Fas-FasL AICD of T cell populations (Akbar et 
al., 1993; Fugier-Vivier et al., 1997; Zarozinski et al., 2000).  Measles virus, vaccinia 
virus (VV), and herpes simplex virus (HSV) have also been shown to induce apoptosis of 
DC (Bosnjak et al., 2005; Engelmayer et al., 1999; Fugier-Vivier et al., 1997; Jones et al., 
2003; Muller et al., 2004), presumably leading to reduced T cell responses.  Infections of 
human or mouse DC with human cytomegalovirus (HCMV), murine cytomegalovirus 
(MCMV), measles virus, adenovirus, respiratory syncytial virus (RSV), VV, or LCMV 
clone 13 can interfere with DC maturation and inhibit MHC and costimulatory molecule 
expression (Andrews et al., 2001; Engelmayer et al., 1999; Moutaftsi et al., 2002; Munir 
et al., 2008; Newton et al., 2008; Servet-Delprat et al., 2000; Sevilla et al., 2004; Smith et 
al., 2005).  Still others have reported that production of virus-induced immune-
suppressive cytokines such as IL-10 or TGF-β (Alonso et al., 2003; Brockman et al., 
2009; Diaz-San Segundo et al., 2009; Newton et al., 2008; Tinoco et al., 2009) or reduced 
production of inflammatory cytokines such as IL-12 (Moutaftsi et al., 2002; Servet-
Delprat et al., 2000; Smith et al., 2005) may suppress T cell outgrowth. 
Immune suppression can have detrimental outcomes that include increased risk of 
superinfections and poor vaccine efficacy.  Some virus infections that are associated with 
increased incidence of superinfections include measles, influenza, RSV, hepatitis viruses, 
and HIV (Alonso et al., 2003; Avadhanula et al., 2006; Brogden et al., 2005; Huang et al., 
2000; Kantzler et al., 1974; Slifka et al., 2003).  Respiratory viruses can induce a 
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favorable niche for the colonization of bacteria by destroying respiratory epithelium and 
inducing expression of bacterial adhesion receptors (Avadhanula et al., 2006; Hament et 
al., 1999).  In addition to creating a favorable environment for bacterial co-infection, 
immune suppression is also often associated with the enhanced risk of superinfections 
during respiratory virus infections (Alonso et al., 2003; Kantzler et al., 1974; Slifka et al., 
2003).  The most obvious example of how immune suppression can increase the risk of 
superinfections is the increased incidence of viral and bacterial infections in HIV-infected 
individuals (Antonucci et al., 2003; Girardi et al., 2001; Smith, 2004).  Although HIV 
directly destroys an entire lymphocyte compartment, many viruses are capable of 
suppressing and/or subverting the immune system in more subtle ways.   
 Vaccination efficacy can be compromised by an ongoing viral infection, and this 
may be linked to this transient virus-induced immune suppression.  A moderate-to-severe 
illness is a CDC-recommended precaution to vaccination; however, even a mild illness 
may reduce vaccine efficacy.   This is not simply due to an interferon response restricting 
the replication of a live virus vaccine, as HCV-infected patients generated reduced 
antibody responses to a recombinant HBV protein vaccine (HB-Vax) compared to 
healthy controls (Wiedmann et al., 2000).  Nematode and malaria infections have also 
been shown to reduce the protective efficacy of heterologous vaccines, whether they be 
live (e.g. BCG) or subunit (e.g. meningococcal polysaccharide) vaccines (Elias et al., 
2005; Greenwood et al., 1980; Su et al., 2006). 
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J. Homeostasis of bystander T cells during acute viral infections 
 Because LCMV induces such a massive CD8 T cell response, many investigators 
have debated how much of the response is antigen-specific and how much might be 
bystander T cell activation.  The issue is further complicated by the loose utilization of 
the term “bystander” in the literature.  The strict definition is that bystander T cells are 
not stimulated through their TCR and, therefore, are not activated in an antigen-specific 
manner.  The problem with this definition is that it may be difficult in some situations to 
determine whether a T cell has been stimulated through its TCR.  This is apparent in the 
context of auto-antigens, where during a virus infection it is unclear whether self peptide-
MHC can provide some TCR signaling in the presence of a virus-induced cytokine 
milieu.  The degeneracy of T cell recognition of peptide-MHC further confounds the 
issue of bystander activation.  It has been estimated that a single TCR may be able to 
recognize up to one million peptide-MHC complexes, leading to cross-reactivity against 
multiple epitopes (Mason, 1998).  Due to the spectrum of affinities a given TCR may 
have for these many peptide antigens, cross-reactivities may be difficult to detect and 
may be misinterpreted as bystander activation.  For the purpose of this thesis, we define 
bystander T cells as T cells not specific for the virus that is driving the T cell response, 
(i.e. they are not activated by viral antigens). In this context, activation is defined as 
induction of T cell proliferation (increase in cell number) and altered expression of a 
subset of activation markers whose regulation is dependent upon TCR stimulation. 
 The LCMV carrier mouse affords a unique model in which to investigate the 
contribution of bystander T cells to the LCMV-induced T cell response since the host T 
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cells are tolerant to the virus.  Adoptive transfer of LCMV-specific memory T cells 
results in a T cell response in which the adoptively transferred T cells proliferate and 
reduce viral titers.  It has been shown in this model that naïve host CD8 T cells do not 
participate in the response by proliferation, blastogenesis, or regulation of activation 
markers (Zarozinski and Welsh, 1997).  In the same study, it was shown that TCR 
transgenic HY CD8 T cells with a fixed TCR also do not participate in the LCMV-
induced T cell response, providing further evidence that LCMV induces little bystander T 
cell activation (Zarozinski and Welsh, 1997). 
 Early techniques to detect virus-specific CD8 T cells (limiting dilution analysis 
and single cell cytotoxicity assays) could only account for approximately 10% of the total 
CD8 T cell response as being LCMV-specific (Moskophidis et al., 1987).  More sensitive 
techniques to define antigen-specific T cell responses (intracellular cytokine staining and 
staining with peptide-MHC multimer complexes) have minimized the expected 
contribution of bystander T cell activation, as 80-95% of the CD8 T cells present at the 
peak of an LCMV response can now be accounted for as LCMV-specific (Masopust et 
al., 2007; Murali-Krishna et al., 1998).  Despite these studies, there are still a variety of 
publications that suggest bystander T cell activation during acute infections; most of 
these studies do not exclude the possibility of cross-reactivity.  
 In support of the theory that cytokines can induce CD8 T cell activation, it has 
been demonstrated that CD8 T cells from naïve mice can secrete IFN-γ in response to 
combinations of IL-2, IL-15, IL-12, and IL-18 in vitro, but only memory phenotype 
(CD44hi) CD8 T cells are capable of IFN-γ production (Berg et al., 2002; 
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Lertmemongkolchai et al., 2001).  Effector and memory CD8 T cells from Listeria 
monocytogenes- or LCMV-infected mice have the capacity to secrete IFN-γ in response 
to IL-12 and IL-18 stimulation in the absence of cognate antigen in vitro (Berg et al., 
2003; Raue et al., 2004).  The enhanced ability of activated CTL to produce IFN-γ in 
response to IL-12 and IL-18 requires initial TCR stimulation by antigens in vivo, which 
induces IL-12 responsiveness via upregulation of IL-12R, that induces IL-18R expression 
and downstream IL-18 responsiveness (Tomura et al., 1998).  IL-12 signaling via STAT4 
induces T-bet expression, which can initiate IFN-γ transcription as well as enhanced 
expression of IL-12Rβ (Afkarian et al., 2002; Takemoto et al., 2006; Yang et al., 2007).  
IL-18, IL-15, IL-21, and IFN-γ itself may also participate in this feedback loop by 
enhancing IFN-γ expression in T cells (Strengell et al., 2003).   In this capacity, it is 
possible that bystander memory CD8 T cells can provide some IFN-γ-mediated cross-
protection during subsequent heterologous infections.  However, naïve bystander CD8 T 
cells are not activated in this manner (Berg et al., 2003).   
 It has also been demonstrated that IL-2 and IL-15 can induce cytolytic potential of 
naïve CD8 T cells in the absence of cognate antigen, but only if T cells are cultured in 
vitro for 3 days and after proliferation and conversion to memory phenotype (CD44hi) 
(Tamang et al., 2006).  This type of activation is similar to the transient “activation” of T 
cells after homeostatic proliferation (Goldrath et al., 2000).  It has also been suggested 
that cytokines such as IFN-αβ can induce the proliferation and activation of naïve T cells 
in the absence of antigen (Tough et al., 1996), but IFN-αβ causes apoptosis of 
lymphocytes, creating immunological space that induces homeostatic proliferation and 
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subsequent “activation” (Goldrath et al., 2000; Kim et al., 2002; McNally et al., 2001).  It 
is also important to note that homeostatic proliferation requires low affinity self-peptide-
MHC and thus is not driven solely by cytokine signals in a purely bystander manner 
(Goldrath and Bevan, 1999; Kieper et al., 2004; Seddon et al., 2000). 
 Bystander T cells can also be affected by chemokines during acute infections.  
CCR5 signals have been shown to affect naïve bystander CD8 T cell trafficking in two 
separate experimental systems.  In one study, it was demonstrated that naïve OT-I CD8 T 
cells could specifically traffic to a non-antigen-laden footpad if a CD4 epitope and CpG 
were administered into that footpad (Castellino et al., 2006).  In another study, it was 
demonstrated that bystander polyclonal CD8 T cells slowed their movement in LNs and 
formed stable conjugates with DCs presenting peptide to TCR transgenic CD8 T cells 
(Hugues et al., 2007).  In both systems, CCR5 signals in the bystander T cells were 
required (Castellino et al., 2006; Hugues et al., 2007). 
 In addition to the non-cognate T-DC conjugates described above, bystander OT-I 
CD8 T cells have also been shown to form contacts with DCs in VV-infected mice 
(Hickman et al., 2008).  These T-DC contacts were longer than T-DC contacts in 
uninfected mice, but shorter than in VV-OVA-infected mice where DCs would be 
presenting cognate peptide (Hickman et al., 2008).  Although bystander CD8 T cells 
make stable non-cognate T-DC conjugates, it is unclear what kind of signals bystander T 
cells may receive through the TCR from non-cognate peptide-MHC in vivo. 
 There are a couple of studies that suggest that naïve CD8 T cells can be sensitized 
or conditioned in a bystander manner to respond differently upon cognate antigen 
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stimulation.  One such study has shown that IL-15 can induce cytolytic potential of naïve 
(CD44hi-depleted) CD8 T cells within 24 hours in vitro (Tamang et al., 2008).  IL-15 did 
not induce grzB expression and cytolysis was perforin-dependent in this in vitro system 
(Tamang et al., 2008).  In a different study, Mycobacterium avium infection conditioned 
OT-I transgenic CD8 T cells to produce IFN-γ in response to a brief anti-CD3 stimulation 
ex vivo (Gilbertson et al., 2004).   This group ruled out typical cross-reactivity by 
demonstrating that the OT-I cells did not proliferate during the infection, but did not 
otherwise determine a mechanism (Gilbertson et al., 2004). 
 Despite the debate of whether T cells can or cannot be activated in a TCR-
independent bystander manner, it is clear that bystander T cells are affected by ongoing 
immune responses.  The examples presented above demonstrate that bystander T cells 
can be affected by cytokines, chemokines, and mature APCs displaying non-cognate 
peptide-MHC.  Additionally, virus-specific T cells recruited later in the immune 
response, or “latecomer” T cells, may also be sensitized by inflammatory signals prior to 
antigen stimulation, and it is likely that a combination of T cells with different signaling 
sequences from cytokine receptors and TCR constitute the total T cell response to 
pathogens.  It is important to investigate how bystander and latecomer T cells may be 
sensitized or conditioned by ongoing immune responses, particularly in respect to how 
those T cells respond to cognate antigen stimulation; that will be the focus of this thesis.   
 37 
Chapter II:  Materials and Methods 
A.  Mice 
 C57BL/6J (Ly5.2+) male mice, B6.Smm.C3H-Tnfsf6gld (gld), B6.129P2-B2m 
tm1Unc/J (β2m KO), B6.129S7-IFNg<tm1Ts>/J (IFN-γ KO), and B6.129P2-Il18tm1Aki/J 
(IL-18 KO) mice were purchased from The Jackson Laboratory (Bar Harbor, ME). 
C57BL/6-H-2Kb<tm1>H-2Db<tm1> (KbDb KO), C57BL/6-H-2Kb<tm1> (Kb KO), 
C57BL/6-H-2Db<tm1> (Db KO), C57BL/6NTac-IL15<tm1>N5 (IL-15 KO) (Kennedy et 
al., 2000) and TCR-LCMV P14/Rag2 knockout mice were purchased from Taconic 
Farms (Germantown, NY).  B6.SJL (Ly5.1+) male and female mice were purchased from 
Taconic Farms or bred within the Department of Animal Medicine at the University of 
Massachusetts Medical School (UMMS).  TCR transgenic mice (P14 (Pircher et al., 
1989), HY (Kisielow et al., 1988), and OT-I (Barnden et al., 1994)), IFN-αβ receptor KO 
mice (IFN-αβR KO) (Muller et al., 1994), B6.MRL-Tnfrsf6lpr (lpr) mice (Andrews et al., 
1978), and B6.129-IL-12β (IL-12 p40 KO) mice were bred at UMMS.  TCR transgenic 
HY mice were crossed to lpr mice to generate HY transgenic T cells expressing a 
mutated Fas protein.  B6.Tg(HY)-Tnfrsf6lprF2 mice (referred to as HY/lpr) were screened 
via surface expressing of the HY TCR and Fas after in vitro anti-CD3 stimulation.  TCR 
transgenic P14 mice were crossed to IFN-αβR KO mice to generate P14 transgenic T 
cells that do not express IFN-αβR.  P14 IFN-αβR KO mice were screened via surface 
expression of Vα2+ TCR and genomic PCR for the knockout IFN-αβR locus.  All mice 
were maintained in accordance with the guidelines of the Institutional Animal Care and 
Use Committee of UMMS.   
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B.  Virus stocks and inoculations 
 LCMV, strain Armstrong, and Pichinde virus, strain AN3739, were propagated in 
baby hamster kidney cells (BHK21) as previously described (Welsh and Seedhom, 2008; 
Yang et al., 1989).  VV, strain WR, was propagated in NCTC 929 cells and purified over 
a sucrose gradient (Selin et al., 1998). VV recombinants expressing LCMV NP or GP 
were kindly provided by Dr. J. Lindsay Whitton (Scripps Research Foundation, La Jolla, 
CA) (Whitton et al., 1988).  MCMV, strain Smith, was propagated in vivo in salivary 
glands of BALB/c mice (Selin et al., 1998).  Mice were injected intraperitoneally (i.p.) 
with 4 x 105 plaque forming units (pfu) of LCMV, 1.5 x 107 pfu of PV, 1 x 106 pfu of 
VV, 6 x 105 pfu of MCMV, 5 x 106 pfu of VV-NP, or 5 x 106 pfu of VV-GP.  The higher 
than wild type dose for VV recombinants is used because the recombinants are 
attenuated, due to the inactivation of the thymidine kinase gene. 
 To induce IFN-αβ in vivo, mice were inoculated with 200 µg poly(I:C) 
(InvivoGen, San Diego, CA) i.p. unless otherwise described.  To activate P14 TCR 
transgenic CD8 T cells in vivo, mice were inoculated with 5 µg GP33-45 13mer peptide or 
GP33-41-labeled DC2.4 cells intravenously (i.v.).  DC2.4 cells were incubated with 1 µM 
GP33-41 for 45 minutes at 37 °C and washed 4 times in HBSS to label.  To block TNF, 
mice were inoculated with 100 µg Enbrel® (etanercept) i.p. (Moreland, 1998).   To block 
TCR signaling, mice were inoculated i.p. with cyclosporin A (CsA; Sigma-Aldrich, St. 
Louis, MO) at a dose of 40 mg/kg diluted in olive oil (Sigma-Aldrich).  To deplete NK 
cells, mice were inoculated i.v. with 25 µg anti-NK1.1 (PK136) or IgG2a (Cl.18.4) 
isotype control (BioXcell, West Lebanon, NH).  To deplete CD4 T cells, mice were 
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inoculated i.v. with 100 µg anti-CD4 (GK1.5) antibody or IgG2b (LTF-2) isotype control 
(BioXcell).   
 
C.  Adoptive transfers 
 Spleens were harvested from TCR transgenic mice (P14, HY, or OT-I) and single 
cell suspensions were prepared.  Red blood cells were lysed with a 0.84% NH4Cl solution 
and lymphocytes were washed with HBSS.  Where described, cells were labeled with the 
fluorescent dye carboxyfluorescein succinimidyl ester (CFSE) by incubation in 2 µM 
CFSE in HBSS (Invitrogen, Carlsbad, CA) at 37°C for 15 minutes.  For the experiments 
in Chapter III, 5-20 x 105 total splenocytes or 0.5-5 x 105 T cell enriched splenocytes 
from TCR transgenic mice were injected into congenic recipient mice i.v.  For the 
experiments in Chapter IV, 3-10 x 106 total splenocytes or 0.5-5 x 106 T cell enriched 
splenocytes from TCR transgenic mice were injected into congenic recipient mice i.v. 
To enrich for T cells, total splenocytes were stained with biotinylated anti-NK1.1 
(PK136; BD Pharmingen), anti-I-Ab (AF6-120.1; BD Pharmingen), and anti-CD19 (1D3; 
BD Pharmingen) antibodies followed by staining with streptavidin microbeads (Miltenyi 
Biotec, Auburn, CA).  The cells were then passed through a magnetic LS column and the 
flow through was collected.  Enrichment of transgenic T cells was assayed via flow 
cytometry. 
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D.  Synthetic peptides 
 Synthetic peptides were used to stimulate T cell responses in vivo and ex vivo.  
All peptides were purchased from 21st Century Biochemicals (Marlboro, MA) and were 
purified with reverse phase-HPLC to 90% purity.  For ex vivo stimulations, P14 
transgenic T cells were stimulated with the LCMV epitope GP33-41 (KAVYNFATC) 
(Pircher et al., 1989), HY transgenic T cells were stimulated with the Y-chromosome 
encoded Smcy epitope (KCSRNRQYL) (Rocha and von Boehmer, 1991), and OT-I 
transgenic T cells were stimulated with OVA257-264 (SIINFEKL) (Barnden et al., 1994).  
For in vivo stimulations, P14 transgenic T cells were stimulated with the elongated GP33-
45 (KAVYNFATCGIFA) 13mer epitope. 
 Virus-infected mice were tested for host CD8 T cell responses with the following 
peptides:  LCMV and VV-GP infections - GP33-41 (KAVYNFATC); LCMV and VV-NP 
infections - NP396-404 (FQPQNGQFI) (Lewicki et al., 1995); PV infections - PV38-45 
(SALDFHKV) (Brehm et al., 2002); VV, VV-GP, and VV-NP infections - B8R 
(TSYKFESV) (Moutaftsi et al., 2002); and MCMV - M45985-993 (HGIRNASFI) (Gold et 
al., 2002). 
 
E.  Intracellular cytokine and effector molecule staining 
 Cytokine production was evaluated after stimulation with peptides using the 
Cytofix/Cytoperm Kit Plus (with GolgiPlug; BD Pharmingen).  Splenocytes (2-4 x 106) 
were plated in replicates (as many as 10 wells/spleen for some experiments) in 96-well 
plates with 1-5 µM synthetic peptide, 10 U/ml human rIL-2, and 0.2 µl GolgiPlug (BD 
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Pharmingen) for 5 hours at 37°C.  For positive controls, splenocytes were stimulated with 
1 µg purified anti-mouse CD3ε mAb (145-2c11; BD Pharmingen).  Following 
stimulations, splenocytes were washed in flow cytometry buffer (2% FCS in HBSS) and 
blocked with α-Fc (2.4G2; BD Pharmingen) for 15 minutes at 4°C.  Splenocytes were 
then stained with a combination of fluorescently-labeled monoclonal antibodies (mAb) 
specific for CD8 (53-6.7; BD Pharmingen), Ly5.2/CD45.2 (104; BD Pharmingen), 
Ly5.1/CD45.1 (A20; eBioscience (San Diego, CA) or BioLegend (San Diego, CA)), 
Thy1.2/CD90.2 (53-2.1; BD Pharmingen), Thy1.1 /CD90.1 (H1S51; eBioscience), Vα2 
TCR (B20.1; eBioscience), HY TCR (T3.70; eBioscience), CD44 (IM7; BD 
Pharmingen), CD122 (TM-β1; BD Pharmingen), CD62L (MEL-14, BD Pharmingen), 
CD127 (A7R34; eBioscience), and CD43 (1B11; BioLegend) for 20 minutes at 4°C.  
Subsequent fixation and permeabilization of the cells was performed via 
Cytofix/Cytoperm for 20 minutes at 4°C.  Following permeabilization, cells were stained 
with fluorescently-labeled mAbs specific for IFN-γ (XMG1.2; BD Pharmingen or 
eBioscience), TNF (MP6-XT22; BD Pharmingen), and/or GrzB (Invitrogen). Eomes 
protein was stained with anti-mouse/human Eomes (TBR2; eBioscience) after fixation 
and permeabilization with the FoxP3 staining buffer kit (eBioscience) as per 
manufacturer’s instruction.  
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F.  In vivo cytokine production assay 
 To assess in vivo IFN-γ production, mice were inoculated directly with 250 µg 
brefeldin A (Sigma-Aldrich) and GP33-45 13mer peptide i.v.  Six hours later, spleens were 
harvested, single cell suspensions prepared, and stained as described above without the 
need for ex vivo restimulation.  This is a modified protocol that has been previously 
described (Liu and Whitton, 2005). 
 
G.  Degranulation assay 
 To assay the ability of CD8 T cells to undergo antigen-driven degranulation, 
splenocytes were stimulated with synthetic peptides as stated above with the addition of 
0.5 µl/well anti-CD107a (1D4B; BD Pharmingen) and anti-CD107b (ABL-93; BD 
Pharmingen) FITC-labeled antibodies and 0.2 µl/well of GolgiStop (BD Pharmingen).   
 
H.  Apoptosis assays 
 Apoptosis was evaluated via flow cytometry by phosphatidyl serine exposure 
(annexin-V staining), terminal transferase dUTP nick end labeling (TUNEL), and/or 
caspase activation.  For Annexin-V staining, splenocytes were first surface stained with 
the antibodies listed above, followed by washes and staining in Annexin-V binding buffer 
with fluorescently labeled Annexin-V (BD Pharmingen) at a 1:20 dilution for 15 minutes 
at room temperature.  The cells were then washed in Annexin-V binding buffer and 
analyzed immediately via flow cytometry.  For TUNEL analysis, splenocytes were first 
plated in multiple replicates at 2x106 cells/well in 48-well plates and cultured ex vivo at 
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4°C or 37°C for 5 hours.  Cells were then washed and stained with fluorescently-labeled 
mAb in HBSS followed by fixation with Cytofix (BD Pharmingen).  Nuclear membrane 
permeabilization was achieved by incubation in 70% ethanol at -20°C for up to 2 days, 
followed by staining with the Apo-BrdU-Red In Situ DNA Fragmentation Assay Kit 
(BioVision, Mountain View, CA).  To detect caspase activation, splenocytes were first 
surface stained, followed by staining with CaspGLOW fluorescein active stains 
specific for caspase 3 (FITC-DEVD-FMK), caspase 8 (FITC-IETD-FMK), or total 
caspases (FITC-Z-VAD-FMK).  All active caspase stains were purchased from 
BioVision.   
 For some experiments, membrane integrity was analyzed via staining with 7-
aminoactinomycin D (7-AAD; BD Pharmingen) or LIVE/DEAD Fixable Dead Cell Stain 
Kit (Invitrogen). 
 
I.  Cell cycle analysis 
 In addition to the analysis of CFSE dilution to measure cell division, DNA 
content and Ki-67 expression were measured.  DNA content was measured with 
Vybrant DyeCycle (Invitrogen), a cell membrane permeant, DNA-selective, 
fluorescently-labeled dye.  Following surface stains as described above, splenocytes were 
incubated with 100µl of a 1:1000 dilution of Vybrant DyeCycle violet stain for 30 
minutes at 37°C and immediately analyzed by flow cytometry.  Ki-67 expression was 
also measured as a marker for dividing cells by staining cells intracellularly with anti-
human Ki-67 (B56; BD Pharmingen). 
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J.  Flow Cytometry 
 Freshly stained and previously fixed samples were acquired using a BD 
Biosciences LSRII with FACS Diva software and analyzed with FlowJo software 
(Treestar Inc, Ashland, OR).  In order to analyze enough bystander TCR transgenic CD8 
T cells, the threshold for acquisition was set to CD8+ events only, and the storage and 
stoppage gates were set on CD8+ events only.  By setting these parameters, FACS Diva 
ignored all other (CD8-) events that ran through the cytometer and allowed for the 
acquisition of up to approximately 3-4 x 106 CD8 T cell events/sample (approximately an 
entire naïve mouse spleen worth of CD8 T cells).  It should be noted that for most 
experiments in this study 3-6 x 105 CD8+ T cell events were collected/sample. 
 
K.  Functional IFN quantification bioassay 
 Serum and human rIFN-α (PBL Interferon Source, Piscataway, NJ) were serially 
diluted (2-fold) across a 96-well flat bottom plate and NCTC L929 cells were added at 2 
x 104 cells/well.  The following day, 7.5 x 105 pfu vesticular stomatitis virus (VSV) was 
added/well.  Cell morphology and cytopathic effects (CPE) were monitored 2 days post 
infection and the amount of total functional IFN was measured as the last dilution of 
serum or control rIFN-α to provide approximately 50% protection from VSV-mediated 
CPE. 
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L.  RNA isolation and quantitative real-time PCR 
 P14 transgenic CD8 T cells (7-AAD-, CD8+, Vα2+, and congenic marker+) were 
sorted to 93-99% purity on a Mo-Flo sorter (Cytomation, Fort Collins, CO).  RNA was 
isolated from sorted P14 CD8 T cells with an RNeasy kit (Qiagen, Valencia, CA) and 
evaluated spectrophotometrically at 260nm to determine concentration.  cDNA was 
generated using SuperScript III first-strand synthesis system (Invitrogen) on a PTC-200 
Thermo Cycler (MJ Research, Waltham, MA) at 25°C for 10 minutes followed by 50°C 
for 50 minutes.  Relative mRNA concentrations were determined by quantitative real-
time PCR using SYBR Green PCR core reagent kit (Applied Biosystems, Foster City,  
CA) on an iCycler iQ (Bio-Rad, Hercules, CA).   The following primers were used: 
18SrRNA sense 5’-TGGTGGAGGGATTTGTCTGG-3’ and anti-sense 5’-
TCAATCTCGGGTGGCTGAAC-3’, eomesodermin sense 5’-TGAATGAACCTTCCAA 
GACTCAGA-3’ and anti-sense 5’-GGCTTGAGGCAAAGTGTTGACA-3’, T-bet sense 
5’-TTCCCATTCCTGTCCTTCACC-3’ and anti-sense 5’TGCCTTCTGCCTTTCCACA 
C-3’.  For the generation of standard curves, cDNA clones of 18SrRNA, eomesodermin, 
and t-bet were used.  All primers and cDNA plasmid clones were generously provided by 
Dr. Leslie J. Berg. 
 
M.  Statistical Analyses 
 Where appropriate, Student’s t tests were calculated using GraphPad InStat 
software.  Significance was set at p<0.05 and denoted as *p<0.05, **p<0.005, and 
***p<0.0005.  All results are expressed as the mean ± standard deviation. 
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Chapter III: Virus-induced transient immune suppression inhibits antigen-induced 
bystander CD8 T cell proliferation in vivo 
  
Many virus infections induce a transient state of immune suppression that can 
result in superinfections and poor vaccine efficacy.  There is evidence that immune 
suppression can be caused by T cell AICD, DC apoptosis, DC dysfunction, and/or be 
cytokine-mediated.  It has been previously demonstrated that naïve bystander CD8 T 
cells derived from hosts experiencing an acute virus-specific T cell response underwent 
AICD when polyclonally triggered through their TCR in vitro (Zarozinski et al., 2000).  
Susceptibility to AICD could cause immune suppression by inhibiting the development 
of a new T cell response during an ongoing immune response.  In this chapter we sought 
to investigate whether naïve bystander CD8 T cells would be susceptible to immune 
suppression if activated by cognate antigen during an acute viral infection in vivo.  
Consistent with the enhanced susceptibility to cell death noted in vitro, we found that 
bystander CD8 T cells that are activated with cognate antigen in vivo during acute viral 
infections undergo markedly reduced proliferation.  This virus-induced transient immune 
suppression in vivo was associated with a delayed onset of division, which we found not 
to be a defect in antigen presentation, but rather due to a T cell intrinsic defect.  The 
inhibition of TCR-stimulated bystander CD8 T cell proliferation during acute viral 
infections could lead to a superinfection or poor vaccine efficacy, as co-infecting 
pathogen- or vaccine-specific T cells may be unable to mount a sufficient immune 
response. 
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A.  In vivo bystander CD8 T cell models 
 In order to study how bystander and latecomer CD8 T cells are affected by acute 
viral infections, we developed in vivo models to track and specifically activate bystander 
CD8 T cells.  We tested three TCR transgenic CD8 T cells for this purpose and defined 
bystander as a transgenic CD8 T cell population that did not divide or proliferate (lose 
CFSE or increase in cell number), or alter the expression of activation markers (CD44, 
CD43, CD62L) during the viral infection.   
 We found that P14 CD8 T cells, specific for the LCMV epitope GP33-41, did not 
divide, as measured by a lack of dilution of CFSE throughout infection of mice with PV 
(Figure 3.1A).  Additionally, P14 CD8 T cells did not expand in terms of frequency or 
cell number throughout the PV infection and instead were reduced in frequency and 
number during the PV infection, as they may have been susceptible to IFN-αβ-induced 
attrition and got diluted out by the expansion of PV-specific T cells (Figure 3.1B).  P14 
CD8 T cells also remained phenotypically naïve during the PV infection as demonstrated 
by the expression patterns of CD44, CD43, and CD62L (Figure 3.2).  Naïve CD8 T cells 
are CD44lo, CD43lo, and CD62Lhi as shown by the host and P14 CD8 T cells in naïve 
mice (left, grey and black histograms respectively).  Activated PV-specific CD8 T cells 
are CD44hi, CD43hi, CD62Llo, CD127lo and CD122hi as shown by the host CD8 T cells at 
day 5 of PV (right, grey histograms), while the P14 CD8 T cells remained CD44lo, 
CD43lo, and CD62Lhi (right, black histograms).  There was a moderate down-regulation 
of CD127 and up-regulation of CD122 on a portion of the P14 CD8 T cells in the PV-  
 48 
 49 
 
 50 
infected mice, but the expression of these activation markers was not altered to the extent 
of that of the host CD8 T cells, and a majority of the P14 CD8 T cells retained the naïve 
phenotype.  The regulation of CD127 and CD122 activation markers will be discussed 
further in chapter IV. 
 HY transgenic CD8 T cells are specific for the male (Y chromosome-encoded) 
Smcy epitope and remained phenotypically naïve during LCMV infection of female mice.  
HY CD8 T cells did not divide (CFSEhi) and remained CD44lo, CD43lo, CD62Lhi, and 
CD127hi (Figure 3.3).  OT-I CD8 T cells are specific for the SIINFEKL epitope of 
ovalbumin (OVA257-264) and, like the HY CD8 T cells, remained phenotypically naïve 
during LCMV infection (Figure 3.4). 
 We have used these three TCR transgenic CD8 T cell models (P14 + PV, HY or 
OT-I + LCMV) extensively throughout this thesis to study the impact of viral infections 
on bystander CD8 T cells.  We have also used these TCR transgenic CD8 T cells in other 
viral infection models (VV, VV-GP, VV-NP, and MCMV) and have ensured that they are 
bystander by the lack of division, proliferation, and upregulation of CD44 (data not 
shown). 
 
B.  Transient inhibition of TCR-stimulated bystander CD8 T cell proliferation 
during acute viral infections 
 To determine if bystander CD8 T cells were susceptible to immune suppression 
when activated by cognate antigen during an acute viral infection in vivo, we first 
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adoptively transferred HY transgenic CD8 T cells into naïve or day 5 LCMV-infected 
female or male congenic recipients.   Because of their male antigen specificity, HY CD8 
T cells become activated in male but not female mice (Rocha and von Boehmer, 1991).  
Two days later, proliferation was measured by calculating the number of HY CD8 T cells 
in the spleen of each group of mice.  We found a slight reduction in the number of HY 
CD8 T cells recovered from the LCMV-infected female mice compared to the naïve 
female mice, and the HY CD8 T cells that remained had a naïve phenotype.  However, 
the HY CD8 T cells became activated and proliferated in the naïve male mice, resulting 
in an increase in their overall cell number, but this proliferation was greatly inhibited in 
the LCMV-infected male mice (Figure 3.5A).   
 Since the HY CD8 T cells were directly transferred into virus-infected mice, we 
also employed a second model in which P14 CD8 T cells were adoptively transferred into 
naïve congenic recipients, followed by infection with PV.  In this model, the bystander 
CD8 T cells were present in vivo during the entire virus infection.  At day 5 of PV 
infection, mice were inoculated with the highly immunogenic GP33-45 13mer peptide i.v. 
to specifically activate the P14 CD8 T cells.  Two days later, the same time after 
activation as the HY experiment, the number of P14 CD8 T cells in the spleen of each 
group was determined.   Without antigen there was a slight decrease in the number of P14 
CD8 T cells recovered from the PV-infected mice, possibly due to IFN-αβ-induced T cell 
attrition (McNally et al., 2001).  After infusion of GP33-45 antigen the P14 CD8 T cells in 
the naïve mice proliferated, but this proliferation was inhibited in the PV-infected mice, 
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much like the inhibition of proliferation of HY cells in LCMV-infected male mice  
(Figure 3.5B).  These data demonstrate, in two independent experimental models, that 
acute viral infections inhibited the proliferation of TCR-stimulated bystander CD8 T 
cells. 
We next addressed the kinetics of virus-induced immune suppression by 
transferring HY CD8 T cells into naïve or LCMV-infected male mice at days 3, 6, 9, and 
12 post infection and examining the proliferation of HY CD8 T cells 3 days later.  The 
proliferation of HY CD8 T cells activated on day 3 and day 6 of LCMV infection was 
inhibited compared to the proliferation in naïve mice (Figure 3.6).  HY CD8 T cells 
activated on day 3 of LCMV infection had the most pronounced defect in proliferation, 
followed by HY CD8 T cells activated on day 6, day 9, and proliferation was back to 
normal naïve levels at day 12 post infection (Figure 3.6).  In contrast, activation of CD8 
T cells at the onset of virus infection, either involving HY cell transfer immediately prior 
to the time of LCMV infection or GP33-45 inoculation immediately prior to the time of PV 
infection, markedly enhanced the proliferation of the bystander CD8 T cells (Figure 3.7).  
These data indicated that viral infections acted as a stimulatory adjuvant when bystander 
T cells were exposed to the inflammatory milieu and antigens at the beginning of 
infections but were immunosuppressive when bystander T cells engaged antigen as the 
infection progressed.  
Due to the lack of expansion of TCR-stimulated bystander CD8 T cells in Figure 
3.5, we questioned whether there was a specific deletion of cells following TCR 
stimulation in vivo, which we might expect if the cells were susceptible to AICD.  To do
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this, we first investigated the overall kinetics of proliferation by calculating the number of 
P14 CD8 T cells at 0.5, 1, 1.5, 2, 4, and 8 days post peptide inoculation on day 5 of PV 
infection.  First, we found that the number of P14 CD8 T cells activated in the naïve mice  
remained relatively stable until day 1.5, when they began an expansion phase that peaked 
4 days post peptide treatment (Figure 3.8, open diamonds).  In contrast, the P14 CD8 T 
cells activated in PV-infected mice underwent a slight attrition within the first day post 
peptide treatment, but then also proliferated with kinetics similar to that of the naïve mice 
(Figure 3.8, black circles).  At the peak of the proliferative response, day 4 post peptide 
treatment, the total cell number for the P14 CD8 T cells activated in the PV-infected mice 
was greatly reduced compared to the P14 CD8 T cells activated in naïve mice.  These 
data indicated that there was only a moderate attrition of TCR-stimulated P14 CD8 T 
cells following activation, and this cell loss probably could not account for the reduced 
expansion of bystander CD8 T cells activated during acute viral infections. 
 We also utilized the HY LCMV model to ask whether the reduced expansion was 
due to a rapid deletion of TCR-stimulated CD8 T cells by calculating the number of HY 
CD8 T cells just 2 hours post adoptive transfer into naïve and LCMV-infected female and 
male mice.  In this model, we did find that the HY CD8 T cells transferred into the male 
LCMV-infected mice underwent a rapid depletion, prior to division of the cells, and 
supportive of the hypothesis that bystander CD8 T cells may be susceptible to AICD 
(Figure 3.9). 
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C.  Reduced proliferation and rapid depletion of TCR-stimulated bystander CD8 T 
cells is not due to sequestration in peripheral tissues 
 Due to the rapid depletion and reduced expansion of HY CD8 T cells in the 
spleen of LCMV-infected male mice, we asked whether the transgenic cells were being  
sequestered in other tissues.  Trafficking of T cells can altered during viral infection 
(Castellino et al., 2006; Hugues et al., 2007) and cells injected into the tail vein traffic 
through the lungs and liver before reaching the spleen, so it was possible that the HY 
CD8 T cells got trapped in the lung or liver on their way to the spleen following i.v. 
injection, or else got recruited to lymph nodes. We first tested whether the rapid depletion 
of HY CD8 T cells was due to getting trapped in the lung or the liver following i.v. 
injection.  Two hours post transfer, we found a similarly low number of HY CD8 T cells 
in the liver and the lungs of LCMV-infected mice compared to the naïve mice (Figure 
3.10).  There were slightly more HY CD8 T cells in the lungs and livers of the virus-
infected animals.  However, this increase could not account for the loss of cells in the 
spleen, as there were approximately 10-fold fewer HY T cells recovered from the lungs 
and liver than in the spleen.  We also enumerated the number of HY CD8 T cells in the 
spleen, inguinal lymph nodes, bone marrow, peritoneum, lung, and liver two days post 
transfer into male mice and found that HY CD8 T cells could not be recovered in any 
significant number in these tissues, indicating that they were not being specifically 
recruited to any of these other compartments (Figure 3.11).  These data indicated that the 
rapid depletion and reduced proliferation of HY CD8 T cells in the spleen was not due to 
specific trafficking or sequestration in peripheral tissues.   
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D.  Reduced proliferation of TCR-stimulated bystander CD8 T cells in vivo is not 
exclusively mediated by Fas-FasL- or TNF-induced AICD  
 The reduced proliferation of TCR-stimulated bystander CD8 T cells during acute 
viral infections would have been predicted by in vitro studies showing susceptibility of 
virus-induced T cell populations to AICD (Zarozinski et al., 2000).  We therefore tested 
whether the reduced proliferation of defined bystander T cell populations was a 
consequence of AICD in vivo, by testing the influence of Fas-FasL and TNF in this 
process. To investigate the role of Fas-FasL, we studied the fate of HY transgenic T cells 
bred onto the B6.MRL-Tnfrsf6lpr (lpr, Fas mutant) background and the fate of HY or P14 
CD8 T cells in B6.Smm.C3H-Tnfsf6gld (gld, FasL-deficient) mice.  HY/lpr CD8 T cells 
lack a functional Fas surface receptor and cannot, therefore, undergo apoptosis initiated 
by FasL (Nagata and Suda, 1995).  Gld mice lack a functional FasL and cannot, therefore 
initiate apoptosis in Fas-expressing T cells (Nagata and Suda, 1995).  To investigate the 
role of TNF, we treated mice with the human TNF receptor fusion protein Enbrel to 
neutralize serum TNF (Moreland, 1998).  Using these systems we found that HY and P14 
CD8 T cell proliferation was inhibited in virus-infected mice whether Fas-FasL, TNF, or  
both pathways were blocked (Table 3.1), indicating that Fas-FasL and TNF were not 
required for the reduced proliferation of TCR-stimulated bystander CD8 T cells. 
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Table 3.1. Fas-FasL and TNF are not required for the inhibition of TCR-stimulated 
bystander CD8 T cell proliferation2 
# 
Exps TCR Tg Host mice Treatment 
Functional  
Fas-FasL/TNF  
Fold 
inhibition 
7 HY WT  +/+ 4.2 ± 1.4 
8 P14 WT  +/+ 4.4 ± 1.9 
2 HY gld  -/+ 4.9 ± 1.9 
4 HY/lpr WT  -/+ 4.4 ± 1.1 
4 P14 gld  -/+ 4.5 ± 3.7 
3 HY WT Enbrel® +/- 4.0 ± 1.6 
3 P14 WT Enbrel® +/- 5.1 ± 4.5 
1 HY gld Enbrel® -/- 4.3 ± 0.0 
1 HY/lpr WT  Enbrel® -/- 4.1 ± 0.0 
2 P14 gld Enbrel® -/- 3.8 ± 0.9 
  
 
 
 
 
 
 
 
                                                
2 HY or HY/lpr transgenic CD8 T cells were adoptively transferred into naïve or day 5 
LCMV-infected WT or gld recipient male mice.  Two days post adoptive transfer, the 
number of HY CD8 T cells in the spleen of individual mice was determined.  P14 
transgenic CD8 T cells were adoptively transferred into naïve WT or gld recipient mice 
followed by infection with 1.5 x 107 pfu PV i.p.  At day 5 of PV infection, mice were 
inoculated with GP33-45 i.v.  Two days post peptide treatment, the number of P14 CD8 T 
cells in the spleen of individual mice was determined.  Enbrel®-treated mice were 
inoculated i.v. with 100 µg Enbrel® i.p. at day 4 of virus infection (one day prior to 
transgenic T cell activation).  Fold inhibition was calculated as the number of transgenic 
CD8 T cells activated in naïve mice over the number of transgenic CD8 T cells activated 
in virus-infected mice.  The numbers depict the average fold inhibition for all 
experiments performed ± SD. 
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E.  Reduced proliferation of TCR-stimulated bystander CD8 T cells may only 
minimally be due to enhanced susceptibility to apoptosis 
Despite not finding a role for Fas-FasL or TNF in mediating AICD, we further 
explored the possibility that TCR-stimulated bystander CD8 T cells underwent cell death 
through another pathway, particularly due to the rapid depletion of HY CD8 T cells after 
activation in LCMV-infected male mice (Figure 3.9).  We assessed apoptosis by annexin-
V reactivity, TUNEL, and active caspase staining in TCR-stimulated HY and P14 CD8 T 
cells.  Annexin-V reactivity is a measure of phosphatidyl serine exposure on the cell 
membrane and marks cells in the early phase of apoptosis.  The TUNEL assay measures 
DNA fragmentation, which is an outcome of apoptosis, and thus TUNEL staining 
measures late stage apoptosis.  Caspases are a family of cysteine proteases, which play an 
essential role in apoptosis and can be stained with fluorescent inhibitors that will only 
bind the active form.  We used multiple assays to detect apoptosis because it is 
sometimes difficult to assess apoptosis of lymphocytes during acute viral infections 
directly ex vivo because of the rapid clearance system of phagocytes. 
We found that TCR-stimulated HY CD8 T cells in LCMV-infected male mice 
were only slightly more apoptotic as measured by annexin-v reactivity and TUNEL 
staining than TCR-stimulated HY CD8 T cells in naïve male mice (Figure 3.12 and 3.13) 
(HY CD8 T cells averaged 9.3 ± 3.1% annexin-v+ and 16.5 ± 7% TUNEL+ in LCMV-
infected male mice, while HY CD8 T cells averaged 10.7 ± 2.1% annexin-v+ and 12.6 ± 
2.1% TUNEL+ in naïve male mice).  Activated HY CD8 T cells were also slightly more 
apoptotic in naïve hosts than unstimulated HY CD8 T cells (HY CD8 T cells averaged  
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10.7 ± 2.1% annexin-v+ and 12.6 ± 2.1% TUNEL+ in naïve male mice, while HY CD8 T 
cells averaged 8.2 ± 3.9% annexin-v+ and 5.4 ± 1% TUNEL+ in naïve female mice), but 
only the TUNEL data was statistically significant (p = 0.01).  These data indicated that 
activation of HY CD8 T cells induced some apoptosis, but that activation of bystander 
HY CD8 T cells during acute LCMV infection did not significantly drive the cells into 
apoptosis. 
We also found that P14 CD8 T cells stimulated with GP33-45 peptide in PV-
infected mice were also only slightly more apoptotic as measured by annexin-v reactivity 
than GP33-45-stimulated P14 T cells in naïve mice (P14 CD8 T cells averaged 16.5 ± 5.6% 
annexin-v+ in peptide-treated PV-infected mice, while P14 CD8 T cells averaged 10 ± 
2.8% annexin-v+ in peptide-treated naïve mice) (Figure 3.14).  The frequency of P14 
CD8 T cells harboring active caspase 3, caspase 8, or total active caspases increased with 
stimulation, regardless of whether the P14 CD8 T cells were activated during an acute PV 
infection or in naïve mice (Figure 3.15).  It was also apparent that the levels of active 
caspase 3 and caspase 8 were higher in P14 CD8 T cells stimulated with cognate peptide 
in naïve mice compared to PV-infected mice, although only caspase 8 activation reached 
statistical significance (caspase 3 activation in GP33-stimulated P14 CD8 T cells from 
naïve mice versus PV-infected mice: p = 0.06, caspase 8: p = 0.005).  Only total active 
caspases were higher on P14 CD8 T cells activated with GP33-45 peptide in PV-infected 
mice compared to naïve mice, although this difference was not statistically significant (p 
= 0.56). 
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Similar results were obtained at various time points between 1 hour and 8 days 
post T cell activation and in different tissues (spleen, inguinal lymph nodes, bone 
marrow, perotineum, lung, liver, and blood) for both TCR transgenic models (data not 
shown).  These data indicate that the reduced expansion of TCR-stimulated bystander 
CD8 T cells may only minimally be due to enhanced susceptibility to cell death and that 
the mechanisms behind the rapid depletion of HY CD8 T cells in LCMV-infected male 
mice remain unknown. 
 
F.  Reduced proliferation of TCR-stimulated bystander CD8 T cells in vivo is 
associated with delayed division 
 Because the reduced proliferation of TCR-stimulated bystander CD8 T cells could 
not be explained by their death, we questioned whether a defect in division accounted for 
the reduced proliferation.  Thus, CFSE-labeled P14 CD8 T cells were assessed for 
dilution of CFSE at various time points between 0 and 5 days after GP33-45 peptide 
inoculation.  As shown in Figure 3.16A, P14 CD8 T cells activated by GP33-45 in naïve 
mice started to divide approximately 48 hours post peptide treatment and by 120 hours 
many of the P14 CD8 T cells in the naïve mice had fully diluted the CFSE. In contrast, 
only 22.9 ± 8% (n = 12) of the P14 CD8 T cells activated during the acute PV infection 
had divided at least once by 72 hours post peptide treatment compared to 87 ± 6.4% (n = 
10) of P14 CD8 T cells activated in naïve mice at the same 72 hour time point.  It was 
only at 96 hours and later that a larger proportion of P14 cells activated in the PV-
infected mice had divided (Figure 3.16A).   
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The kinetics of CFSE dilution can also be analyzed by calculating the division 
and proliferation indexes.  The division index is a measure of the average number of 
divisions that any cell in the starting population underwent, while the proliferation index 
is the average number of divisions that any divided cell underwent (ignores undivided 
cells). The division and proliferation indexes for P14 CD8 T cells activated by GP33-45 
peptide in naïve mice peaked at 72 hours post peptide treatment, while both indexes were 
still increasing at 120 hours for the P14 cells activated in PV-infected mice (Figure 
3.16B).   
In addition to assessing CFSE dilution, we also measured the frequency of P14 
CD8 T cells in different phases of the cell cycle at 0, 3, 4, and 5 days post GP33-45 peptide 
treatment.  This was achieved with the use of a DNA-specific fluorescent dye, and cells 
in G0-G1, S, and G2-M phases of the cell cycle were separated by the intensity of 
fluorescence (a measure of the amount of DNA).  Although this is a less precise 
measurement of division, because any divided CFSElo cell could be in G0-G1 at any 
given point, it is still a useful measure of division of a population as a whole.  We found 
that 3 days post peptide treatment, fewer P14 CD8 T cells in naïve mice were in G0-G1 
and more cells were in G2-M phases of the cell cycle compared to day 0.  In contrast, 
there was not an increase in the frequency of P14 CD8 T cells in G2-M at day 3 post 
peptide treatment in the PV-infected mice, although the difference between the naïve 
mice and PV-infected mice at this time point were not quite statistically different (p = 
0.09).  There was not a significant increase in the frequency of P14 cells in G2-M phases 
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of the cell cycle until 5 days post peptide treatment for the P14 CD8 T cells activated 
during the acute PV infection (Figure 3.17A).  Additionally, the expression of Ki-67 is 
often used as a marker of cell division (Gerdes et al., 1983), and P14 CD8 T cells 
activated with GP33-45 in naïve mice up-regulated Ki-67 within 3 days post peptide 
treatment.  This up-regulation, however, was delayed in the P14 CD8 T cells activated in 
the PV-infected mice (Figure 3.17B).  The kinetics of CFSE dilution, cell cycle 
progression, and Ki-67 expression suggested that there was a delay in the division of 
TCR-stimulated bystander P14 CD8 T cells during acute viral infection. 
 
G.  Reduced proliferation of TCR-stimulated bystander CD8 T cells is not due to a 
defect in antigen presentation during acute viral infection 
 The delayed onset of TCR-stimulated bystander CD8 T cell division could be a T 
cell intrinsic defect or could be a consequence of aberrant antigen presentation during the 
acute viral infections.  Antigen presentation could be inhibited because of DC apoptosis 
or the reduced expression of MHC or costimulatory molecules during acute viral 
infections.  Since our experiments rely on host APCs to present the endogenous male 
Smcy epitope to HY CD8 T cells or the inoculated GP33-45 peptide to P14 CD8 T cells, we 
asked if the proliferation of bystander CD8 T cells could be rescued if exogenous GP33-41-
pulsed DCs were administered to PV-infected mice instead of GP33-45 peptide.  We 
inoculated naïve and PV-infected mice with 107 DC (unpulsed) or DC-GP33 (peptide- 
pulsed) cells i.v. and measured the division and proliferation of the P14 CD8 T cells two 
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days later.   The administration of DC-GP33 activated the P14 CD8 T cells in naïve mice 
to divide (Figure 3.18A) and proliferate (Figure 3.18B).  The division and proliferation of 
P14 CD8 T cells in response to DC-GP33 were inhibited in the PV-infected mice, much 
like they were in response to peptide infusion, suggesting that the reduced proliferation of 
P14 CD8 T cells in PV-infected mice was not due to a defect in the processing or 
presentation of the GP33-45 peptide, but was a T cell intrinsic defect.  Additionally, we 
found that the frequency of total CD11c+ DC in the spleen at day 5 of PV (1.7 ± 0.17%) 
was not different than that found in naïve mice (1.5 ± 0.08%), indicating that DC 
apoptosis was probably not the cause of reduced T cell proliferation. 
 As an alternative approach, we asked whether bystander HY CD8 T cells from 
LCMV-infected female mice could proliferate normally if transferred into uninfected 
male mice displaying the cognate ligand.  If the reduced proliferation of HY CD8 T cells 
in LCMV-infected male mice was due to a defect in antigen presentation during the virus 
infection, then we would predict that HY CD8 T cells from LCMV-infected female mice 
would be able to proliferate normally when transferred into naïve male mice.  To do this, 
we directly infected HY transgenic female mice with LCMV, harvested splenocytes from 
naïve and day 5 LCMV-infected HY transgenic female mice, enriched for T cells using 
magnetic beads, and transferred equal numbers of naïve donor HY or bystander donor 
HY CD8 T cells into naïve male recipient mice.   The bystander donor HY CD8 T cells 
were not able to divide or proliferate to the extent of naïve HY CD8 T cells in the naïve 
male recipient mice (Figure 3.19).  These data indicate that the defect in proliferation of 
HY CD8 T cells in LCMV-infected male mice was not due to a defect in antigen  
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presentation, but was a T cell intrinsic inhibition.  It was possible that this experimental 
setup resulted in the transfer of virus from the LCMV-infected HY mice to the naïve 
male mice, but we noted that the host CD8 T cells in the naïve male mice receiving 
LCMV-infected HY T cells remained CD44lo and CD62Lhi, suggesting that little to no 
virus was transferred (data not shown).  Taken together, these data demonstrate that the 
inhibition of TCR-stimulated bystander CD8 T cell proliferation was not due to a defect 
in antigen presentation during the acute viral infections, but was probably a T cell 
intrinsic defect. 
 
H.  Conclusions 
 Many viruses induce a transient state of immune suppression, and there is in vitro 
evidence linking immune suppression to T cell AICD, aberrant co-stimulation, and DC 
dysfunction.  Due to the lack of consensus from in vitro systems, we sought to investigate 
the transient immune suppression induced by acute infections with the arenaviruses 
LCMV and PV using adoptive transfer models to track and specifically activate TCR 
transgenic bystander CD8 T cells in vivo (Figure 3.1-3.3).  In this chapter we demonstrate 
that the proliferation of bystander CD8 T cells activated by cognate antigen during the 
early acute phase of virus infection in vivo was inhibited (Figure 3.5).  Susceptibility to 
immune suppression was transient, as by day 12 post infection, TCR-stimulated 
bystander CD8 T cells underwent normal proliferation (Figure 3.6), yet the proliferation 
 
 
 81 
of TCR-stimulated bystander CD8 T cells was enhanced if the T cells were activated 
immediately prior to the viral infection (Figure 3.7).  Thus, while there was a strong 
adjuvant effect of viral infections on T cell proliferation at the beginning of infection, 
there was a strong suppression of T cell proliferation as early as three days into the 
infection.  Our studies focused on T cells with specificities for ligands other than those 
encoded by the infecting virus, but we presume that these findings would be relevant to 
latecomer virus-specific T cells whose TCR do not encounter antigen until later in 
infection.  Despite the susceptibility of bystander CD8 T cells to AICD in vitro 
(Zarozinski et al., 2000), we found that the reduced proliferation of bystander CD8 T 
cells in vivo was not exclusively mediated by Fas-FasL- or TNF-induced AICD (Table 
3.1).  In addition, we could not convincingly show an enhanced susceptibility to 
apoptosis in vivo (Figures 3.12-3.15), though it should be noted that apoptotic cells can 
sometimes be cleared in vivo before they are readily detectable.  Nevertheless, most of 
the inhibition in antigen-induced proliferation could be explained by a delay in the onset 
of division (Figures 3.16 and 3.17), that was a T cell intrinsic defect (Figures 3.18 and 
3.19). 
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Chapter IV: IFN-αβ  and self-MHC induce Eomes and sensitize naïve bystander 
CD8 T cells to rapid effector functions during acute viral infections 
 
Due to the delayed proliferation of TCR-stimulated bystander CD8 T cells, we 
sought to determine if the effector functions of such T cells were altered by ongoing 
acute viral infections.  In order to do this, we utilized the TCR transgenic bystander T cell 
models described in chapter III, except that for most experiments described in this 
chapter, bystander CD8 T cells were isolated and activated with cognate peptide in vitro.  
Despite the suppression of TCR-stimulated bystander CD8 T cell proliferation in vivo, we 
found an enhancement of the effector functions exerted by bystander CD8 T cells 
activated during acute viral infections.  During acute viral infections or after stimulation 
with type 1 IFN (IFN-αβ) inducers, some bystander CD8 T cells were sensitized to 
immediately exert effector functions such as IFN-γ production and degranulation upon 
stimulation with high affinity cognate antigen.  Sensitization of naïve CD8 T cells 
required self-MHC I and indirect effects of IFN-αβ, while IL-12, IL-18, and IFN-γ were 
not individually required.  IL-15 was not required for the rapid expression of IFN-γ, but 
was required for up-regulation of GrzB.  P14 and OT-I CD8 T cells, which are capable of 
homeostatic proliferation, could be sensitized by poly(I:C), but HY CD8 T cells, which 
are poor at homeostatic proliferation, could not, suggesting that the requirement for MHC 
I may be to present low affinity cryptically cross-reactive self antigens.  Sensitized naive 
CD8 T cells up-regulated the t-box transcription factor Eomes, which was dependent on 
IFN-αβ and MHC I, and can regulate these rapid effector functions. 
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A.  Naïve bystander CD8 T cells are transiently sensitized to rapidly express IFN-γ 
upon cognate antigen stimulation during acute viral infection and poly(I:C) 
treatment 
 In order to determine if virus infections altered the effector functions of TCR-
stimulated bystander CD8 T cells, we first asked how naïve P14 CD8 T cells would 
respond if activated with cognate peptide GP33-41 at day 5, during the early acute phase of 
PV infection.  This would simulate the activation of bystander CD8 T cells during a 
superinfection or the activation of virus-specific latecomer CD8 T cells.  To address this, 
we adoptively transferred P14 transgenic CD8 T cells into congenic recipients and 
infected mice with PV the following day.  At day 5 post infection we harvested spleens 
and stimulated the spleen leukocytes with cognate peptide GP33-41 specific to the P14 
cells for 5 hours ex vivo.  As predicted, naive P14 CD8 T cells isolated from naïve mice 
produced very little IFN-γ in response to GP33-41 stimulation.  However, a substantial 
number of the P14 CD8 T cells from the PV-infected mice were able to rapidly express 
IFN-γ after, and only after, GP33-41 stimulation in vitro (Figure 4.1A).  IFN-γ expression 
was induced between 2 and 4 hours post peptide stimulation (Figure 4.1B), with kinetics 
similar to effector and memory CD8 T cells.  Additionally, if mice were inoculated 
directly with brefeldin A, to block golgi-mediated cytokine secretion, and the highly 
immunogenic GP33-45 13mer peptide simultaneously i.v, the P14 CD8 T cells residing in 
PV-infected mice began expressing IFN-γ in vivo within 6 hours of peptide inoculation 
(Figure 4.2).  The PV-induced sensitization to rapid IFN-γ expression was transient, as 
the ability to rapidly express IFN-γ in response to cognate antigen was decreased at day  
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15 and was down to background levels by day 20 post PV infection (Figure 4.3).   
Together, these data show that an acute viral infection transiently sensitized naïve 
bystander CD8 T cells to rapidly initiate IFN-γ synthesis in response to cognate peptide 
stimulation with kinetics similar to effector and memory CD8 T cells. 
We next questioned whether a pro-inflammatory state, in the absence of a virus 
infection, could sensitize bystander CD8 T cells to the rapid induction of IFN-γ in 
response to cognate peptide.  To do this, we adoptively transferred P14 transgenic CD8 T 
cells followed by inoculation with the potent IFN-αβ-inducer poly(I:C).  We found that 
poly(I:C), like PV, could sensitize P14 CD8 T cells to rapid IFN-γ expression upon GP33-
41 stimulation and, although the kinetics were different than the PV infection, the 
sensitization of P14 CD8 T cells by poly(I:C) was also transient (Figure 4.4).   
We also questioned whether poly(I:C) treatment could sensitize polyclonal naïve 
CD8 T cells to rapidly turn on expression of IFN-γ in response to an anti-CD3 
stimulation.  We found that, like P14 T cells, polyclonal CD8 T cells in untreated mice 
were poor producers of IFN-γ, and of all the IFN-γ-producing cells, most of them were of 
an effector or memory phenotype (CD44hi) as the average ratio of CD44hi:CD44lo IFN-γ+ 
CD8 T cells was 8.2 (3 independent experiments, n=12) (Figure 4.5).  After poly(I:C) 
treatment, many CD44hi CD8 T cells undergo IFN-αβ-induced apoptosis (Bahl et al., 
2006; McNally et al., 2001), as reflected by a loss of IFN-γ-producing CD44hi CD8 T 
cells in Figure 4.5.  Concomitant with the loss of IFN-γ+ CD44hi CD8 T cells, there was 
an increase in the frequency of IFN-γ+ naïve CD44lo CD8 T cells, as the average ratio of  
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CD44hi:CD44lo IFN-γ+ CD8 T cells was reduced to 0.94 (3 independent experiments, 
n=14). This change in ratio was partly due to the apoptotic loss of CD44hi CD8 T cells, 
but it also reflected an increase in the absolute number of IFN-γ-producing CD44lo naïve 
CD8 T cells (Figure 4.5B).  The ability of naïve phenotype CD44lo CD8 T cells to rapidly 
produce IFN-γ in response to anti-CD3 was also enhanced during PV infection 
(frequency of IFN-γ+ CD44lo CD8 T cells after anti-CD3 stimulation from naïve mice = 
0.33% ± 0.1, n=10; frequency of IFN-γ+ CD44lo CD8 T cells after anti-CD3 stimulation 
at day 5 of PV infection = 0.98% ± 0.6, n=15).  The differences in the frequencies of 
IFN-γ-producing polyclonal CD8 T cells and transgenic P14 CD8 T cells could be 
partially due to the stimulation conditions, as we found that P14 CD8 T cells activated by 
cognate peptide were better able to rapidly express IFN-γ than P14 cells activated with 
anti-CD3 (frequency of IFN-γ+ P14 CD8 T cells after GP33-41 stimulation = 25.3% ± 9; 
frequency of IFN-γ+ P14 CD8 T cells after anti-CD3-stimulation = 12.5% ± 5, from the 
same 4 experiments, n=25). This may indicate that a larger proportion of the naïve 
polyclonal population is sensitized than the anti-CD3 experiment would predict and that 
anti-CD3 is not as good a stimulus as a cognate peptide.  
 
B.  Induction of granzyme B and enhanced antigen-driven degranulation of naïve 
bystander CD8 T cells during acute viral infection and poly(I:C) treatment 
 Due to the ability of naïve bystander CD8 T cells in virus-infected or poly(I:C)-
treated mice to rapidly express the effector cytokine IFN-γ upon cognate antigen 
stimulation, we questioned whether these naïve bystander CD8 T cells would also have 
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the ability to be cytolytic.  We measured their expression of GrzB immediately ex vivo 
and their ability to undergo antigen-driven degranulation in vitro by staining for the 
surface expression of LAMP-1 and LAMP-2 (CD107a and CD107b) in response to GP33-
41 stimulation.  In the absence of exposure to cognate GP33-41 ligand, GrzB was induced in 
P14 CD8 T cells after poly(I:C) treatment in terms of the frequency of P14 cells 
expressing GrzB (%) and the relative amount of GrzB per cell (MFI) (Figure 4.6A).  
GrzB induction was even greater in naïve P14 CD8 T cells during PV infection, 
especially in terms of GrzB expression per cell.  The ability of P14 CD8 T cells to 
undergo antigen-driven degranulation, as measured by surface expression of CD107, was 
also significantly enhanced for P14 CD8 T cells after poly(I:C) treatment and PV 
infection (Figure 4.6B).  It is also noteworthy that after GP33-41 stimulation, bystander-
sensitized P14 CD8 T cells lose some GrzB expression (average ratio of GrzB MFI in 
P14 CD8 T cells after peptide stimulation over no stimulation = 0.87 ± 0.009 from 3 
independent experiments, n = 15), suggesting that the enhanced degranulation may be of 
some GrzB-containing particles.  PV infection and poly(I:C) treatment can thus sensitize 
naive P14 CD8 T cells such that they will upregulate GrzB prior to cognate antigen 
stimulation in vivo and prime cells for IFN-γ production and degranulation upon ligand 
exposure in vitro. 
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C.  Not all viral infections sensitize all bystander CD8 T cells to exert rapid effector 
functions: roles for IFN-αβ and cryptic cross-reactivity  
 To determine whether other viral infections could sensitize P14 CD8 T cells and 
whether TCR transgenic CD8 T cells of other specificities could be sensitized, we 
examined the sensitization of P14, HY, and OT-I transgenic CD8 T cells by LCMV, PV, 
VV, and MCMV.  Examples from 8 independent experiments showing the IFN-γ 
production of cognate peptide-stimulated TCR transgenic CD8 T cells from all of these 
models are shown in Figure 4.7.  The cumulative data generated from >30 experiments 
using all of these models are listed in Table 4.1, which depicts the average ratio of 
cognate peptide-induced IFN-γ production for TCR transgenic CD8 T cells in 
infected/treated mice over the IFN-γ production for transgenic CD8 T cells from control 
mice.  P14 CD8 T cells were sensitized to rapidly express IFN-γ in response to cognate 
peptide stimulation by PV and poly(I:C), but not by VV or MCMV.  HY transgenic CD8 
T cells were not sensitized by any of the stimuli, and OT-I CD8 T cells were sensitized 
well by LCMV and moderately by PV and poly(I:C) (Figure 4.7 and Table 4.1). 
 
D.  Indirect effects of IFN-αβ  are required for the sensitization of naïve bystander 
CD8 T cells  
 Due to the ability of LCMV, PV, and poly(I:C) to sensitize naïve CD8 T cells and 
the inability of VV, a poor inducer of IFN-αβ, to do so, we questioned whether IFN-αβ 
levels correlated with the sensitization process.  Mice were thus inoculated with 10-fold  
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Table 4.1.  Not all virus infections or pro-inflammatory stimuli sensitize bystander 
CD8 T cells3 
 Virus infection or pro-inflammatory stimulus 
TCR Tg LCMV PV VV MCMV Poly(I:C) 
P14 N/A 5.8±4 1.1±0.09 1.1±0.1 5.8±5 
HY 0.93±0.13 0.96±0.04 0.5±0.5 1.4±0 0.66±0.3 
OT-I 2.9±2 1.7±0.6 1.2±0.4 ND 2.1±0.2 
 
                                                
3 P14, HY, or OT-I transgenic CD8 T cells were adoptively transferred into naïve 
congenic recipients followed by infection with 5x104 pfu LCMV, 1.5x107 pfu PV, 1x106 
pfu VV, 6x105 pfu MCMV, or 200 µg poly(I:C) i.p.  At day 5 post infection (or day 1 
post poly(I:C) inoculation), splenocytes were stimulated with GP33, Smcy, or SIINFEKL 
peptides ex vivo.  Each transgenic population was gated and the ability of the transgenic T 
cells to produce IFN-γ in response to its cognate peptide was assessed.  Numbers depict 
the average ratio of IFN-γ production from infected/treated mice over IFN-γ production 
from naïve/untreated mice stimulated with cognate peptide ± standard deviation from >30 
total experiments. N/A – not applicable and ND – not done. 
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 dilutions of poly(I:C) from 0.01-100 µg/mouse.  Decreasing the dose of poly(I:C) 
resulted in lower induction of total functional IFN, as assessed by a VSV-mediated CPE 
inhibition bioassay (Figure 4.8A).  There was a linear correlation between the amount of 
functional IFN induced and the ability of P14 CD8 T cells to rapidly express IFN-γ in 
response to GP33-41 stimulation (r2 = 0.560, p < 0.005, n = 32) (Figure 4.8B).  Likewise, 
we also found correlations between the induction of functional IFN and the up-regulation 
of GrzB (r2 = 0.563, p < 0.005, n = 18) and the ability of T cells to undergo enhanced 
antigen-driven degranulation (r2 = 0.389, p < 0.05, n = 18) (Figure 4.8C,D). 
 We next asked if IFN-αβ was required for the sensitization of naïve P14 CD8 T 
cells by using IFN-αβR KO mice, which induce less total functional IFN than the WT 
mice (Figure 4.9B), likely due to the inhibition of a positive feedback loop initiated by 
IFN-α4 and IFN-β signaling (Marie et al., 1998; Sato et al., 1998a).  We found that P14 
CD8 T cells were less efficiently sensitized to rapidly express IFN-γ in response to 
cognate peptide stimulation in the poly(I:C)-treated IFN-αβR KO mice compared to WT 
mice (Figure 4.9A).  These results are consistent with the correlation of total functional 
IFN and the ability of P14 CD8 T cells to rapidly express IFN-γ (Figure 4.8B) and 
suggest that IFN-αβ is required for the sensitization of naïve bystander CD8 T cells 
during acute viral infections and poly(I:C) treatment. 
Knowing that IFN-αβ was involved in the sensitization of bystander CD8 T cells, 
we next asked whether direct or indirect IFN-αβ signals were required.  In order to 
address whether direct IFN-αβ signals were required, P14 transgenic mice were crossed 
to IFN-αβR KO mice to generate P14 CD8 T cells that did not express the IFN-αβR and  
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thus could not respond directly to IFN-αβ signals.  WT or IFN-αβR KO P14 CD8 T cells 
were adoptively transferred into congenic WT or IFN-αβR KO recipients, which were 
then inoculated with poly(I:C).  In the IFN-αβR KO host mice, WT or IFN-αβR KO P14 
CD8 T cells (WT→KO and KO→KO) were much less efficiently sensitized by poly(I:C) 
than either type of P14 cells in WT host mice (WT→WT and KO→WT) (Figure 4.10A).  
The most pronounced defect in IFN-γ production was the KO→KO group, but the ratio 
of IFN-γ+ P14 CD8 T cells for the poly(I:C)-treated mice over the untreated mice in this 
group was similar to the WT→KO group.  These data indicated that IFN-αβ was required 
for sensitization, but direct IFN-αβ signals on the P14 CD8 T cells were not required for 
their sensitization. 
 
E.  Influence of other cytokines and cytokine-producing cells on sensitization 
 Due to the indirect requirement for IFN-αβ in the sensitization of naïve P14 CD8 
T cells, we questioned whether IFN-αβ was inducing sensitization by way of another 
mediator.  NK cells are activated by IFN-αβ (Welsh, 1978), and CD4 T cells can be Th1-
skewed by IFN-αβ (Way et al., 2007), so it was possible that NK cells or CD4 T cells, 
perhaps by secreting IFN-γ, were mediating the sensitization of the P14 CD8 T cells.  To 
address this, we depleted mice of NK cells or CD4 T cells prior to poly(I:C) inoculation. 
Depletion of NK cells or CD4 T cells did not affect the sensitization of P14 CD8 T cells 
after poly(I:C) treatment (Figure 4.11).  Further, P14 CD8 T cells were sensitized by 
poly(I:C) in IFN-γ KO mice (Figure 4.12A) and administration of a dose of neutralizing  
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antibody to IFN-γ, known to be effective in other studies in our laboratory (Chen et al., 
2001), also did not inhibit the sensitization of P14 CD8 T cells (data not shown).  We 
questioned whether another cytokine induced by viral infections and poly(I:C) could be 
mediating sensitization.  Since IL-12, IL-15, and IL-18 have been shown to induce IFN-γ 
expression by effector and memory CD8 T cells (Berg et al., 2002; Berg et al., 2003; 
Lertmemongkolchai et al., 2001; Raue et al., 2004), we tested the requirements for these 
cytokines by using cytokine knockout mice.  We found that none of these cytokines, at 
least individually, were required for the poly(I:C)-induced sensitization of naive P14 CD8 
T cells to rapid IFN-γ production (Figures 4.12B,C and Figure 4.13A).  Each knockout 
mouse group induced a slightly lower frequency of IFN-γ-producing P14 CD8 T cells 
than did their WT counterparts, but these differences were not statistically significant 
(poly(I:C)-treated WT versus IFN-γ KO: p = 0.89, poly(I:C)-treated WT versus IL-12 
KO: p = 0.06, poly(I:C)-treated WT versus IL-18 KO: p = 0.35, and poly(I:C)-treated 
WT versus IL-15 KO: p = 0.71).  We did notice, however, that IL-15 was required for up- 
regulation of GrzB (Figure 4.13C) and may also play a role in the enhanced 
degranulation in response to cognate peptide stimulation (Figure 4.13B).  Antigen-driven 
degranulation of P14 CD8 T cells was reduced in the poly(I:C)-treated IL-15 KO mice in 
2 independent experiments, but these results did not reach statistical significance (p = 
0.11, n = 7) (Figure 4.13B and data not shown). 
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F.  MHC I is required for the sensitization of naïve bystander CD8 T cells 
 The fact that CD8 T cells of different specificities would be sensitized differently 
by poly(I:C) suggested that their TCR may play a role in sensitization.  T cells are 
selected in the thymus for their low avidity to self antigens, and naïve T cells require 
MHC-presented self antigens to undergo homeostatic proliferation (Goldrath and Bevan, 
1999; Kieper et al., 2004; Seddon et al., 2000).  Notably, female HY transgenic CD8 T 
cells are known to be poor at homeostatic proliferation in female mice (Kieper et al., 
2004; Lin et al., 2007) and could not be sensitized in our systems.  This suggested that 
low affinity cryptically cross-reactive self-antigen in the presence of pro-inflammatory 
signals may sensitize P14 and OT-I CD8 T cells, which readily undergo homeostatic 
proliferation.  If this were the case, CD8 T cell sensitization would require TCR signaling 
by class I MHC. 
To test the requirement for pMHC-TCR, we first sought to determine if P14 CD8 
T cells could be sensitized by poly(I:C) in β2m knockout mice, which poorly express  
class I MHC (Koller et al., 1990; Lehmann-Grube et al., 1994).  We compensated for the 
lack of MHC I antigen presentation ex vivo by providing congenic naïve splenocytes to 
efficiently present the GP33-41 peptide to the P14 CD8 T cells.  Naïve T cells make TNF 
but not IFN-γ on exposure to their MHC-displayed ligand (Brehm et al., 2005), and this 
set up allowed us to control for TCR stimulation in vitro, as under these conditions of 
stimulation P14 cells taken from β2m KO mice produced TNF in response to GP33-41 
(Figure 4.14A).  However, P14 CD8 T cells from poly(I:C)-treated β2m KO mice were 
unable to rapidly express IFN-γ in response to peptide stimulation (Figure 4.14A,B),  
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suggesting that they required class I antigen presentation in vivo for sensitization.  This 
difference between β2m KO and WT mice was not due to a defect in IFN-αβ induction, 
because similar levels of functional IFN were induced in both strains of mice at 1 day 
post poly(I:C) inoculation (Figure 4.14C). 
 In addition to the requirement for class I antigen presentation, we also asked 
whether TCR stimulation was required for the sensitization of naïve P14 CD8 T cells in 
poly(I:C)-treated mice also treated with cyclosporin A (CsA).  CsA is an inhibitor of the 
Ca2+-dependent phosphatase calcineurin and blocks T cell activation (O'Keefe et al., 
1992; Trenn et al., 1989).  This was a technically challenging experiment to design 
because of the need to optimize doses and kinetics which would prevent TCR stimulation 
in vivo yet allow for TCR stimulation with cognate peptide ex vivo.  We found that, 
consistent with the requirement for class I antigen presentation, TCR stimulation may 
also be required for the priming of naïve P14 CD8 T cells, as CsA treatment reduced the 
frequency of P14 CD8 T cells that could rapidly express IFN-γ, but not TNF (Figure  
4.15A,B). The difference was not quite statistically significant (p = 0.16), but if the P14 
cells were capable of activation by cognate peptide ex vivo, there is a possibility that they 
received some TCR signaling by self-MHC in vivo prior to the time of sacrifice.   
We also questioned whether cognate MHC (H2Db for P14) was required for 
sensitization or if any MHC I could sensitize the P14 CD8 T cells.  To address this, we 
adoptively transferred P14 CD8 T cells into congenic WT, KbDb KO, Kb KO, and Db KO 
mice, followed by inoculation with poly(I:C).  As shown in Figure 4.16, P14 CD8 T cells 
were only sensitized in mice expressing H2Db (WT and Kb KO).  Their ability to rapidly  
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express IFN-γ and undergo enhanced degranulation in response to cognate peptide 
stimulation was abrogated in mice lacking H2Db but still expressing H2Kb (Figure 
4.16A,B).  The immediate ex vivo expression of granzyme B was up-regulated in the P14 
CD8 T cells after poly(I:C) inoculation in all of the mice, but this up-regulation was 
diminished in those mice lacking H2Db (Figure 4.16C), suggesting that there is some 
MHC I-independent regulation of GrzB expression.   Importantly, the inability of P14 
CD8 T cells to be sensitized in mice lacking H2Db was not due to a defect in IFN 
induction (Figure 4.16D) or due to an inability to be activated in vitro, as the P14 CD8 T 
cells from all recipient mice could induce TNF expression in response to GP33-41 
stimulation (Figure 4.16E).   P14 CD8 T cells also could not be sensitized by H2d MHC 
alleles, as P14 CD8 T cells were refractory to sensitization by poly(I:C) in BALB/c mice 
(ratio of IFN-γ+ P14 cells in poly(I:C)-treated Balb/c mice over untreated mice = 1.2 from 
2 independent experiments, n = 10).  These data suggest that cognate MHC (H2Db) 
displaying cryptic (i.e. unidentified) self peptides were required for the sensitization of 
naïve P14 CD8 T cells after poly(I:C) treatment. 
Although we have defined the P14 CD8 T cells as bystander, it was apparent that 
they were receiving some signal through their TCR during acute viral infections and after 
poly(I:C) treatment.  We questioned whether this cryptic TCR signal induced any other 
phenotypic changes.  Despite remaining CD44lo, CD43lo, and CD62Lhi, sensitized P14 
CD8 T cells down-regulated IL-7Rα (CD127) after poly(I:C) treatment (Figure 3.2 and 
4.17), but HY CD8 T cells, which could not be sensitized for IFN-γ production,  only 
minimally down-regulated IL-7Rα (Figure 4.17A).  Other signals in addition to TCR  
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stimulation have been shown to down-regulate IL-7Rα, including IL-7 itself (Vranjkovic 
et al., 2007), but we found that blocking TCR signaling in vivo with CsA prevented the 
down-regulation of IL-7Rα (Figure 4.17B) and the down-regulation of IL-7Rα was 
reduced in mice lacking H2-Db (data not shown).  However, some down-regulation of IL-
7Rα did occur after poly(I:C) inoculation of KbDb KO mice and Db KO mice, suggesting 
that other signals that can potentially be inhibited by CsA, in addition to TCR 
stimulation, may contribute the down-regulation of IL-7Rα.   
Because OT-I CD8 T cells were sensitized by LCMV and not by VV, we asked 
whether VV-recombinant viruses expressing the LCMV NP or GP (VV-NP or VV-GP 
respectively) could sensitize the OT-I CD8 T cells.  We found that VV-NP could 
marginally sensitize OT-I cells, but this sensitization was not much greater than WT VV 
(Figure 4.18).  Since IFN-αβ was required for sensitization and VV is a poor IFN-αβ 
inducer, we questioned whether VV-NP could sensitize OT-I cells if IFN-αβ was also 
induced.  To do this, we adoptively transferred OT-I transgenic CD8 T cells, infected 
mice with VV or VV-NP, and on day 2 some mice in each infection group were also 
inoculated with poly(I:C) to induce IFN-αβ.  On day 5, we assayed the ability of the OT-
I CD8 T cells to produce IFN-γ in response to SIINFEKL stimulation ex vivo.  As shown 
in figure 4.18, poly(I:C) increased the sensitization by VV-NP but not by WT VV, 
suggesting that both IFN-αβ and a potential low affinity LCMV NP epitope, that does not 
activate the T cells in a typical fashion, may drive the sensitization of OT-I CD8 T cells.  
The increase in IFN-γ production by OT-I CD8 T cells in VV-NP + poly(I:C)-treated 
mice was not quite statistically significant over VV (p = 0.08), VV + poly(I:C) (p = 0.37),  
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or VV-NP (p = 0.19), but these data suggest that pathogen-encoded peptides may also be 
able to sensitize bystander CD8 T cells and further work is needed to substantiate these 
findings. 
 
G. IFN-αβ- and MHC I-dependent induction of Eomes in sensitized P14 CD8 T cells 
during PV infection and poly(I:C) treatment 
 IFN-γ gene transcription is regulated by chromatin accessibility and by the 
expression of appropriate transcription factors.  The t-box transcription factors T-bet and 
Eomes are important transcription factors in the regulation of CTL effector genes (Cruz-
Guilloty et al., 2009; Intlekofer et al., 2008; Intlekofer et al., 2005; Mayer et al., 2008; 
Pearce et al., 2003; Sullivan et al., 2003).  We questioned whether T-bet or Eomes were 
induced in bystander-sensitized CD8 T cells, thus enabling those cells to rapidly exert 
effector functions.   P14 CD8 T cells from naïve, LCMV day 6 (effector), LCMV day 40  
(memory), poly(I:C) day 1, PV day 5, and PV day 20 infected mice were purified by cell 
sorting immediately ex vivo and without any exposure to cognate ligand.  Their RNA was 
then extracted and used for quantitative real-time PCR to quantify mRNA levels of the 
transcription factors.   As shown in Figure 4.19A and consistent with published reports, 
effector CD8 T cells up-regulated mRNA for T-bet (6-fold) and Eomes (4-fold), and 
memory CD8 T cells further up-regulated Eomes (8-fold) but not T-bet mRNA (Cruz-
Guilloty et al., 2009; Takemoto et al., 2006).   The sensitized bystander P14 CD8 T cells 
up-regulated Eomes, but not T-bet mRNA, after poly(I:C) inoculation and PV infection.  
Poly(I:C) induced about a 2-fold induction of Eomes, and PV infection induced about 4- 
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fold induction over naïve levels (Figure 4.19A).  Importantly, the high expression of 
Eomes mRNA in bystander CD8 T cells was transient, and by day 20 after PV infection, 
at a time in which the P14 CD8 T cells could no longer rapidly express IFN-γ (Figure 
4.3), the level of Eomes mRNA was below that detected in naïve CD8 T cells.  
 Eomes protein was also induced in sensitized P14 CD8 T cells after PV infection 
and poly(I:C) treatment and was expressed directly ex vivo without a requirement for 
exposure to GP33-41 (Figure 4.19B).  Strikingly, most of the P14 CD8 T cells up-regulated 
Eomes protein after poly(I:C) treatment (71% ± 7.7, n = 8), a frequency nearly twice that 
(38% ± 9, n = 8) of the cells that rapidly synthesized IFN-γ  in response to GP33-41 
stimulation ex vivo (Figure 4.19B).  Importantly, about half of the polyclonal naïve CD8 
T cells in WT B6 mice also up-regulated Eomes expression after poly(I:C) treatment 
(Figure 4.20B), arguing that this up-regulation is a common event and not restricted to 
only a rare transgenic T cell population.  
Since MHC I and indirect effects of IFN-αβ were required for the sensitization of 
P14 CD8 T cells to rapidly express IFN-γ in response to cognate antigen, we also tested 
whether these signals were required for the induction of Eomes.  To address this, we 
measured the induction of Eomes protein in P14 and naïve (CD44lo) host CD8 T cells in 
H2Db KO and IFN-αβR KO mice.  As shown in Figure 4.20A, P14 CD8 T cells did not 
up-regulate Eomes protein in response to poly(I:C) treatment in H2Db KO KO mice, 
supporting the concept that recognition of MHC was needed for sensitization.  In 
contrast, induction of Eomes protein in naïve polyclonal CD8 T cells in the H2Db KO 
mice was like that of wild-type (Figure 4.20B), indicating that these host CD8 T cells,  
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which had been selected in a MHC H2Kb environment, received sufficient stimulation for 
sensitization.   Neither donor P14 cells nor polyclonal host naïve cells were sensitized in 
mice lacking receptors for IFN-αβ (Figure 4.20A,B), probably due to the diminished 
induction of IFN-αβ (Figure 4.9B).  Taken together, these data show that IFN-αβ and 
cognate MHC I are required for the up-regulation of Eomes in bystander-sensitized CD8 
T cells, and we suggest that the expression of this transcription factor allows for the rapid 
synthesis of IFN-γ in response to cognate antigen stimulation. 
Additionally, another known target of Eomes is the β chain of the IL-2R and IL-
15R, CD122 (Intlekofer et al., 2005), which was not up-regulated to the level on virus-
specific CD8 T cells, but was moderately induced on bystander P14 and naïve polyclonal 
CD8 T cells during acute viral infection and after poly(I:C) treatment (Figure 3.2) as the 
average ratio of CD122 MFI on CD44lo naïve CD8 T cells from PV-infected mice over 
untreated mice was 1.6 ± 0.4 (3 independent experiments, n = 12), suggesting that Eomes  
expression in bystander-sensitized CD8 T cells may also induce IL-15 responsiveness.  
This is interesting given the result that IL-15 was required for the up-regulation of GrzB 
and possibly for enhanced degranulation of bystander-sensitized P14 CD8 T cells after 
poly(I:C) treatment (Figure 4.13B,C).   
 
H.  Conclusions 
We demonstrate in this chapter that IFN-αβ-inducing acute viral infections and 
TLR agonists sensitize naïve phenotype bystander CD8 T cells to gain a transient ability 
to rapidly express IFN-γ in response to high affinity cognate antigen (Figures 4.1-4.5).  
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Bystander-sensitized CD8 T cells also up-regulated GrzB prior to high affinity cognate 
antigen engagement and underwent enhanced antigen-driven degranulation after cognate 
antigen stimulation (Figure 4.6), suggesting that they may also be cytolytic.  Associated 
with this acquisition of effector functions was the up-regulation of mRNA for the t-box 
transcription factor Eomes, known to regulate CTL effector functions (Figure 4.19).  
Hence, these naïve bystander T cells were conditioned to behave like memory cells on 
exposure to high affinity cognate ligand. 
Taken together, we propose the model shown in Figure 4.21, whereby the 
arenaviruses LCMV and PV and the TLR agonist poly(I:C) induce IFN-αβ (Merigan et 
al., 1977; Welsh, 1978).  IFN-αβ has pleotropic effects on many cell types, including the 
up-regulation of MHC I and the induction of cytokines, including IL-15 (Samuel, 2001; 
Zhang et al., 1998b).  We propose that the enhanced expression of MHC I during these 
inflammatory conditions results in TCR signaling by low affinity cryptically cross-
reactive self peptide-MHC.  These signals up-regulate the t-box transcription factor 
Eomes, which allows for the rapid expression of IFN-γ upon cognate antigen stimulation.  
Eomes-induced up-regulation of CD122 and concomitant IL-15 responsiveness also 
regulates the expression of GrzB and perhaps the ability of bystander or latecomer CD8 T 
cells to undergo enhanced antigen-driven degranulation.  Therefore, inflammatory signals 
during acute viral infections initiate the sensitization of naive bystander and latecomer 
CD8 T cells such that they will rapidly exert effector functions upon cognate antigen 
stimulation. 
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Chapter V: Discussion 
  
We demonstrate in this thesis that naïve bystander and latecomer CD8 T cells are 
affected by inflammatory signals during acute viral infections such that their response to 
cognate antigen stimulation is altered.  Prior to cognate antigen engagement, bystander 
CD8 T cells up-regulated Eomes, CD122, and GrzB.  Following cognate antigen 
engagement, bystander CD8 T cells rapidly degranulated and expressed the effector 
cytokine IFN-γ.  The ability of bystander CD8 T cells to rapidly exert effector functions 
may contribute to the resistance of virus-infected individuals to superinfections.  Despite 
these rapid effector functions, the proliferation of TCR-stimulated bystander CD8 T cells 
was markedly inhibited.  This reduced proliferation was found not to be a defect in 
antigen presentation, but was a T cell intrinsic defect in initiating division.  Thus, 
bystander CD8 T cells were also susceptible to virus-induced immune suppression.   
It is also likely that virus-specific CD8 T cells that are not activated until later in 
the response, so-called latecomer CD8 T cells, may also be susceptible to immune 
enhancement and suppression.  Thus, latecomer CD8 T cells would be able to rapidly 
exert effector functions at the expense of proliferation.  Taken together, we propose the 
model shown in Figure 5.1, whereby virus-specific CD8 T cells activated early during 
infection have the highest proliferative potential, but do not have the ability to rapidly 
exert effector functions.  In contrast, sensitized bystander and latecomer CD8 T cells that 
are activated during the infection are able to rapidly exert effector functions at the 
expense of proliferation.  Suppression in the form of reduced proliferation was not 
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caused by the ability to exert rapid effector functions, as demonstrated by HY CD8 T 
cells.  The HY cells are not sensitized to rapidly exert effector functions in female mice 
due to the lack of self-antigen signals, yet still undergo poor proliferation when activated 
during an acute viral infection.  It is conceivable that sensitized bystander CD8 T cells 
would be immediately able to respond and limit the early replication of a superinfecting 
pathogen without having to first undergo multiple rounds of proliferation.  Furthermore, 
sensitized latecomer CD8 T cells could immediately respond to the ongoing infection 
while early-activated virus-specific CD8 T cells have already commenced their 
proliferative phase.  Taken together, we propose that during an immune response, due to 
spatial and temporal gradients of antigen and inflammation, it is likely that a combination 
of heterogeneous T cells with different signal strengths and sequences of exposure from 
cytokines and peptide-MHC constitute the total T cell response to pathogens. 
 In chapter IV, we demonstrate that IFN-αβ-inducing acute viral infections and 
TLR agonists sensitize naïve phenotype bystander CD8 T cells to gain an ability to 
rapidly express IFN-γ in response to high affinity cognate antigen (Figures 4.1-4.5).  
Bystander-sensitized CD8 T cells also up-regulated GrzB prior to high affinity cognate 
antigen engagement and underwent enhanced antigen-driven degranulation after cognate 
antigen stimulation (Figure 4.6), suggesting that they may also be cytolytic.  Associated 
with this acquisition of effector functions was the up-regulation of the t-box transcription 
factor Eomes (Figure 4.19), known to regulate CTL effector functions.  Hence, these 
naïve bystander T cells were conditioned to behave like memory cells on exposure to 
high affinity cognate ligand. 
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 The sensitization likely required low affinity MHC-TCR interactions that did not 
fully activate the T cells, because if MHC I was reduced, absent, or of the wrong allotype 
or if TCR signaling was inhibited by CsA treatment, sensitization was reduced (Figures 
4.14-4.16).  The specificity of the TCR also likely played a role, as P14 and OT-I CD8 T 
cells could be sensitized by poly(I:C), but HY CD8 T cells could not (Figure 4.7 and 
Table 4.1).  We questioned whether this sensitization event was a general occurrence 
among bystander cells and found that during PV infection or after poly(I:C) treatment 
about 1-3% of the naïve non-transgenic CD8 T cells gained the ability to rapidly express 
IFN-γ in response to anti-CD3 stimulation (Figure 4.5).  This small percent may, 
however, be a substantial underestimate of the sensitized cell population, as anti-CD3 
was inefficient at measuring the sensitization of P14 cells, in comparison to the cognate 
peptide. Further, about half of naïve host polyclonal CD8 T cells synthesized Eomes 
protein after poly(I:C)  (Figure 4.20B), arguing that a substantial proportion of the T cells 
may become sensitized by virus-induced cytokines and that once sensitized, their 
response to cognate ligand would be altered.   
The rules for the T cell differentiation events determined by studying naïve T 
cells from unstimulated mice would be different for T cells first exposed to virus-induced 
cytokines.  It could thus be predicted that latecomer T cells recruited at later stages of an 
immune response would behave differently than those stimulated at the beginning of a 
response.  Further, because different responses were seen in transgenic T cells of 
different specificities, it could be argued that this bystander sensitization may provide a 
spectrum of T cells receiving a variety of strength of signals and perhaps ultimately 
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inducing different fates.  It is likely, therefore, that some cells would become highly 
sensitized, while others would not, and some may be in an intermediate state.  Cells that 
do not become sensitized may be more like the HY transgenic T cells, because of the 
absence of sufficient quantities of self male ligand in female mice that would enable them 
to undergo homeostatic proliferation.  Although sensitization probably required TCR 
stimulation through pMHC, bystander CD8 T cells were not activated in a typical 
fashion, as they remained phenotypically naïve and did not divide or proliferate during 
the virus infection (Figure 3.1-3.4).  Nevertheless, they received some signal that induced 
expression of mRNA and protein for Eomes, which are known to be induced by TCR 
stimulation (Cruz-Guilloty et al., 2009).  The signals emanating from the TCR of 
bystander-sensitized T cells in vivo are currently unknown.  Antagonist and partial 
agonist APLs can induce p21 phosphorylated TCR-ζ and partially bound non-
phosphorylated ZAP-70 (Madrenas et al., 1995; Sloan-Lancaster et al., 1994), so it will 
be of interest to determine the status of the phosphorylation events in bystander-
sensitized T cells in vivo.  It will also be of interest to examine phosphorylation after 
cognate antigen stimulation ex vivo to determine if the TCR signaling cascade is altered 
when sensitized CD8 T cells are activated by cognate antigen compared to naïve CD8 T 
cells from untreated mice. 
There are still a number of questions regarding the MHC-TCR interactions 
involved in CD8 T cell sensitization during acute viral infections.  For instance, we find 
that P14 CD8 T cells can only be sensitized by H2Db, which is the MHC responsible for 
presenting the cognate epitope GP33-41.  However, it is unknown if P14 CD8 T cells are 
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selected only on H2Db in the thymus.  Further, it is unknown whether naïve CD8 T cells 
can only be sensitized by the selecting-MHC I.  Additionally, we found that MHC II-
restricted LCMV GP61-specific TCR transgenic CD4 T cells (SMARTA) could not be 
sensitized by PV (data not shown).  However, it is currently unknown whether CD4 T 
cells of other specificities and/or other virus infections or inflammatory responses could 
sensitize CD4 T cells.  Since CD4 T cells do not express Eomes, it is also of interest to 
determine whether T-bet could function like Eomes in the sensitization of CD4 T cells. 
Sensitization also required IFN-αβ but not direct IFN-αβ signaling on the CD8 T 
cells (Figures 4.8-4.10).  IFN-αβ did not sensitize CD8 T cells by way of NK cells or 
CD4 T cells, nor were IFN-γ, IL-12, IL-15, or IL-18 required, at least individually, for the 
sensitization to rapid IFN-γ production (Figures 4.11-4.13).  Nevertheless, it is possible 
that combinations of IFN-γ, IL-12, IL-15, and IL-18 signals could sensitize P14 CD8 T 
cells, because combinations of these cytokines can promote IFN-γ production by effector 
and memory CD8 T cells better than any of them individually (Berg et al., 2002; Raue et 
al., 2004).  Due to the requirement for MHC I (Figures 4.14-4.16), it is probable that one 
indirect role of IFN-αβ during PV infection or poly(I:C) treatment is to up-regulate 
expression of MHC I, which may then signal the T cells.  T cells are positively and then 
negatively selected in the thymus under conditions when IFN is not up-regulating MHC, 
and it has been a mystery why T cells selected at one threshold of MHC do not become 
auto-aggressive during viral infections which induce high levels of IFN, which in turn 
enhances MHC expression throughout the host (Bukowski and Welsh, 1985).  Here we 
show that these T cells may become sensitized but not fully activated by the enhanced 
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expression of self-MHC during acute viral infections.  Full activation only occurs on 
exposure to their high affinity ligand and not to cryptically cross-reactive self-ligands 
present in the host.  The simplest explanation of our results would be that the IFNαβ-
induced upregulation of class I MHC was all that was needed to sensitize the T cells.  We 
cannot, however, rule out that other indirect IFN-induced events modulate this process. 
Many viral and bacterial infections induce IFN-αβ via signaling through TLR and 
RLR pathways so it is likely that the sensitization of T cells demonstrated in this study is 
not restricted to arenavirus infections of mice.  Interestingly, MCMV infection induces 
IFN-αβ (Zuniga et al., 2008) but was not able to sensitize P14 CD8 T cells (Table 4.1).  
This result is interesting given the fact that MCMV encodes a few immune evasion genes 
known to inhibit class I antigen presentation (Kavanagh and Hill, 2001).  During MCMV 
infection, the up-regulation of MHC I, and thus the enhanced presentation of low affinity 
self-antigens, may be inhibited by a class of MHC I retention genes (including m152 and 
m6) (Kavanagh and Hill, 2001; Wagner et al., 2002).  Although it is unknown whether 
the up-regulation of MHC I on infected cells mediates sensitization, it will be of interest 
to determine if MCMV mutant viruses specifically knocked-out in MHC I retention genes 
(Δm152 (Krmpotic et al., 1999) and/or Δm6 (Wagner et al., 2002)) are able to sensitize 
P14 CD8 T cells. 
IFN-γ transcription is a tightly controlled process, regulated by chromatin 
accessibility and the expression of transcription factors.  The t-box transcription factors 
T-bet and Eomes play an essential role in the induction of IFN-γ transcription in virus-
specific CD8 T cells (Intlekofer et al., 2008; Intlekofer et al., 2005; Mayer et al., 2008; 
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Sullivan et al., 2003).  We found that Eomes was transiently induced in bystander-
sensitized CD8 T cells during PV infection and poly(I:C) treatment and all IFN-γ-
producing P14 CD8 T cells were Eomesmid-hi (Figure 4.19).  This probably imparts the 
ability to rapidly express IFN-γ in response to high affinity cognate antigen.  
Additionally, another known target of Eomes, the β chain of the IL-2R and IL-15R, 
CD122 (Intlekofer et al., 2005), was moderately induced on bystander P14 and naïve 
polyclonal CD8 T cells during acute viral infection and after poly(I:C) treatment (Figure 
3.2), suggesting that Eomes expression in bystander-sensitized CD8 T cells may also 
induce IL-15 responsiveness.  This is interesting given the result that IL-15 was required 
for the up-regulation of GrzB and possibly for enhanced degranulation of bystander-
sensitized P14 CD8 T cells after poly(I:C) treatment (Figure 4.13B,C).  IFN-αβ has been 
shown to induce expression of IL-15 (Zhang et al., 1998b), among other cytokines and 
IL-15 can induce GrzB and perforin expression and concomitant cytolytic ability of CD8 
T cells (Liu et al., 2002; Tamang et al., 2008; Tamang et al., 2006). It is unknown 
whether Eomes-induced expression of CD122 is required for this process, although we 
did find some up-regulation of GrzB in the absence of cognate MHC I (Figure 4.16C), 
suggesting that full up-regulation of GrzB may require Eomes-induced IL-15 
responsiveness. 
A very limited number of publications have demonstrated effector functions 
mediated by naïve CD8 T cells.  In one report, Mycobacterium avium infection 
conditioned OT-I transgenic CD8 T cells to produce IFN-γ in response to a brief anti-
CD3 stimulation ex vivo (Gilbertson et al., 2004).   This group ruled out typical cross-
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reactivity by demonstrating that the OT-I cells did not proliferate during the infection, but 
the expression of activation markers such as CD44 and the role of self MHC were not 
assessed. (Gilbertson et al., 2004).  Mycobacterium infections induce the expression of an 
array of pro-inflammatory cytokines including IL-1, IL-6, IL-12, IL-15, IL-18, and IFN-γ 
(van Crevel et al., 2002), which may have the capacity to mediate the sensitization of OT-
I CD8 T cells in addition to cryptic cross-reactive TCR stimulation.  Another study has 
demonstrated that IL-15 could induce cytolytic potential of naïve (CD44hi-depleted) 
polyclonal CD8 T cells in vitro (Tamang et al., 2008).  In that system IL-15 did not 
induce GrzB expression and cytolysis was perforin-dependent, but it further supports the 
hypothesis that IL-15 may regulate the cytolytic ability of naïve CD8 T cells. 
Virus infections have been implicated as a risk factor for transplant rejection and 
autoimmunity.  Virus-induced IFN-αβ has been shown to break transplantation tolerance 
induced by costimulation blockade (Miller et al., 2008; Thornley et al., 2007). 
Costimulation blockade induces apoptosis of allo-reactive T cells, and it was 
demonstrated that TLR agonists and recombinant IFN-β could prevent the deletion of 
allo-reactive T cells (Thornley et al., 2007), but it is also possible that sensitization of 
allo-reactive T cells may also function in this process.  Thus, Eomes-expressing allo-
reactive T cells induced by a virus infection could facilitate rapid graft rejection, but the 
role of Eomes in breaking transplantation tolerance has yet to be assessed.  
Viral infections have also had a longstanding association with certain autoimmune 
diseases.  There are several mechanisms described as to how viral infections could induce 
or exacerbate autoimmune diseases, including the induction of general inflammatory 
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responses, cross-reactivity, and bystander lymphocyte activation (Munz et al., 2009).  
Mouse models have uncovered roles for T cell cross-reactivity between pathogen-
encoded and self-antigens, but pathogen-derived triggers of human autoimmune diseases 
have been difficult to identify (Munz et al., 2009).  If auto-reactive T cells can be 
sensitized during acute viral infections, the precise self- or pathogen-encoded epitopes 
would be difficult to identify, as we have shown that sensitization does not alone induce a 
typical T cell response (proliferation, regulation of activation markers, etc.).  It is likely 
that sensitization would be driven by non-cognate self- or pathogen-derived epitopes and 
that sensitized auto-reactive T cells may have to encounter cognate self-antigen for auto-
immunity to ensue.  Because sensitized T cells remain phenotypically naïve during the 
viral infection, their contribution to auto-immunity has yet to be uncovered.  
During an ongoing immune response the ability of a small proportion of naïve 
bystander CD8 T cells to rapidly exert effector functions in response to a superinfecting 
pathogen may prevent an invasion by such a pathogen.  Acute viral infections often 
render hosts resistant to superinfecting viruses, despite transient states of immune 
suppression where proliferative T cell responses to recall antigens are inhibited, as shown 
in chapter III.  Resistance to superinfection may well be due to the IFN-αβ levels 
generated during infection, but we suggest that bystander-sensitized T cells may also 
function in this process.   It is also possible that virus-specific CD8 T cells, particularly 
those that are not activated early in infection, or so-called latecomer T cells, may also be 
sensitized like bystander CD8 T cells.  In this regard, latecomer T cells would be 
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immediately able to produce effector cytokines and to lyse virus-infected cells without 
having to proliferate and may immediately assist in clearing the pathogen.   
Many viruses induce a transient state of immune suppression, and there is in vitro 
evidence linking immune suppression to T cell AICD, aberrant co-stimulation, and DC 
dysfunction.  Due to the lack of consensus from in vitro systems, we sought to investigate 
the transient immune suppression induced by acute infections with the arenaviruses 
LCMV and PV using adoptive transfer models to track and specifically activate TCR 
transgenic bystander CD8 T cells in vivo (Figures 3.1-3.3).  In Chapter III, we 
demonstrated that the proliferation of bystander CD8 T cells activated by cognate antigen 
during the early acute phase of virus infection in vivo was inhibited (Figure 3.5).  
Susceptibility to immune suppression was transient, as by day 12 post infection, TCR-
stimulated bystander CD8 T cells underwent normal proliferation (Figure 3.6), yet the 
proliferation of TCR-stimulated bystander CD8 T cells was enhanced if the T cells were 
activated immediately prior to the viral infection (Figure 3.7).  Thus, while there was a 
strong adjuvant effect of viral infections on T cell proliferation at the beginning of 
infection, there was a strong suppression of T cell proliferation as early as three days into 
the infection.  Our studies focused on T cells with specificities for ligands other than 
those encoded by the infecting virus, but we presume that these findings would be 
relevant to latecomer virus-specific T cells whose TCR do not encounter antigen until 
later in infection.  Despite the susceptibility of bystander CD8 T cells to AICD in vitro 
(Zarozinski et al., 2000), we found that the reduced proliferation of bystander CD8 T 
cells in vivo was not exclusively mediated by Fas-FasL- or TNF-induced AICD (Table 
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3.1).  In addition, we could not convincingly show an enhanced susceptibility to 
apoptosis in vivo, though it should be noted that apoptotic cells can sometimes be cleared 
in vivo before they are readily detectable.  Nevertheless, most of the inhibition in antigen-
induced proliferation could be explained by a delay in the onset of division (Figure 3.12-
3.15).  
Infections of human or mouse DC with HCMV, MCMV, measles virus, 
adenovirus, RSV, VV, or LCMV clone 13 can interfere with DC maturation and inhibit 
MHC and costimulatory molecule expression (Andrews et al., 2001; Engelmayer et al., 
1999; Moutaftsi et al., 2002; Munir et al., 2008; Newton et al., 2008; Servet-Delprat et 
al., 2000; Sevilla et al., 2004; Smith et al., 2005), and measles virus, VV, and HSV have 
been shown to induce apoptosis of DC (Bosnjak et al., 2005; Engelmayer et al., 1999; 
Fugier-Vivier et al., 1997; Jones et al., 2003; Muller et al., 2004), all of which can 
presumably lead to reduced T cell responses.  However, we found that administration of 
peptide-labeled DC could not rescue the inhibition of bystander CD8 T cell proliferation 
(Figure 3.18), suggesting that DC dysfunction in vivo was not the cause of immune 
suppression during acute infections of mice with PV.  Additionally, the reduced 
expression of the homeostatic chemokines CCL21 and CXCL13 in lymphoid organs 
during acute viral infections has been postulated to inhibit the development of new T cell 
responses by hindering the localization of naïve T cells with DCs during ongoing anti-
viral immune responses (Mueller et al., 2007).   This does not appear to be the cause of 
immune suppression in our models because the bystander donor HY CD8 T cells 
sensitized by virus infection in female mice could not proliferate to the extent of naïve 
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HY CD8 T cells when transferred into uninfected male mice (Figure 3.19), where there 
should be normal APC and normal gradients of chemokines expressed.   
Although we could demonstrate reduced proliferation and delayed division with 
both P14 and HY CD8 T cell models, it remains unknown as to the mechanisms behind 
the rapid depletion of the HY CD8 T cells in LCMV-infected male mice (Figure 3.9).  
We could not convincingly show that the HY CD8 T cells underwent apoptosis when 
transferred directly into the LCMV-infected male mice (Figures 3.12 and 3.13), nor could 
we recover the cells in other tissues (Figures 3.10 and 3.11).  One could speculate that the 
up-regulation of adhesion receptors on blood vessel walls during viral infection 
(Thomsen et al., 2003) could bind the T cells soon after they were injected into the tail 
vein, and thus prevent them from reaching any specific tissue.  However, if this were the 
mechanism of depletion, it would also have to require antigen, as there were significantly 
more HY T cells recovered from LCMV-infected female mice.  Whole mouse fluorescent 
microscopy (Reinhardt et al., 2001) may be a useful tool to locate the HY CD8 T cells in 
this model. 
Inhibition of TCR-stimulated bystander CD8 T cell proliferation could result in 
reduced vaccine efficacy if vaccines are administered during an acute viral infection.  The 
long-term fate of the bystander CD8 T cells in our models is unknown, as these models 
are not suitable for studying the differentiation and maintenance of memory CD8 T cells.  
The P14 system relies on peptide treatment to activate the CD8 T cells without engaging 
CD4 T cell help.  Thus the generation and maintenance of functional memory P14 CD8 T 
cells may be compromised in the control naïve mice because of this lack of help.  The 
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HY system relies on the high and constant expression of antigen in male mice, which has 
been shown to eventually anergize adoptively transferred female HY CD8 T cells rather 
than driving them into memory pools (Rocha and von Boehmer, 1991).  Other model 
systems have investigated the role of inflammation in the development of T cell memory.  
Lack of inflammation during T cell activation, via DC immunization, has been shown to 
enhance the rate at which T cells acquire memory characteristics (Badovinac et al., 2005; 
Joshi et al., 2007).  And simultaneous exposure of T cells to bacteria- or CpG-induced 
inflammation inhibited this rapid transition to memory (Joshi et al., 2007; Pham et al., 
2009), but prior exposure of T cells to CpG-induced inflammation 2 days before DC 
immunization did not inhibit the rapid transition to memory (Pham et al., 2009).  
Although we cannot study the long term fate of TCR-stimulated bystander CD8 T cells 
using our models, we know that these naïve T cells are capable of immediate effector 
functions, including IFN-γ production and degranulation when exposed to cognate ligand 
(Chapter IV).  The ability to rapidly exert effector functions was associated with the up-
regulation of the t-box transcription factor Eomes, which required IFN-αβ and self 
peptide-presenting MHC I.  Thus, bystander CD8 T cells had acquired a characteristic of 
memory prior to any TCR stimulation.  We propose that CD8 T cells that receive 
inflammatory signals prior to cognate peptide-induced TCR stimulation are diverted 
down a differentiation pathway that is represented by the rapid acquisition of effector 
functions at the expense of proliferation.  Thus, bystander-sensitized CD8 T cells 
behaved more like short-lived effector cells (SLEC) than memory precursor cells 
(MPEC), despite the expression of Eomes.  Inflammation in the form of IL-12 can tip the 
 135 
balance toward increased SLEC development, but T-bet, not Eomes, is the primary CTL 
transcription factor that controls that cell fate decision (Joshi et al., 2007). Thus, the kind 
and duration of inflammatory stimuli before, during, or after T cell activation may have 
diverse implications in the development and maintenance of memory.  Models utilizing 
different inflammatory stimuli and immunization schemes will have to be established to 
investigate the long-term fate of TCR-stimulated bystander and latecomer CD8 T cells, 
particularly in regards to how vaccine-induced immunity may be compromised during 
acute viral infections. 
In conclusion, we have shown in this thesis that acute viral infections impact 
naïve bystander and latecomer CD8 T cells such that their response to cognate antigen is 
altered.  Prior to cognate antigen engagement, bystander CD8 T cells up-regulate Eomes, 
CD122, and GrzB.  Following cognate antigen engagement, bystander CD8 T cells 
rapidly degranulate GrzB-containing particles and express the effector cytokine IFN-γ. 
Despite these rapid effector functions, the proliferation of TCR-stimulated bystander 
CD8 T cells was markedly inhibited.  This reduced proliferation was found not to be a 
defect in antigen presentation, but was a T cell intrinsic defect in initiating division.  
Finally, we propose that the virus-specific CD8 T cell response is composed of a 
heterogeneous population of T cells that have received different strengths and sequences 
of TCR and cytokine receptor stimulation that will impact their ability to exert effector 
functions, proliferate, and potentially develop into memory.  Dissecting these signals will 
help define how T cells respond to infectious pathogens and aid in the development of 
more efficacious vaccination strategies. 
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